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Introduction 
After the publication of the genomes1-5 of many organisms6, including humans3, the next 
collective challenge is to assign and understand the functions of the final genome products – 
proteins. For example, the Structural Biology Roadmap is an effort to create a "picture" 
gallery of the molecular shapes of proteins in the body. These three dimensional insights are 
crucial for an understanding of basic life processes, such as the reaction mechanism of a 
drug-converting enzyme, signal transduction from one protein to another, activation of a 
metabolic pathway by a gene effector, or the consequences of a mutation on the function of 
an enzyme. Furthermore, understanding of these cellular pathways may allow recognition of 
a disease-linked mechanism of a protein, thereby opening the way to design suitable 
inhibitors or drugs to inhibit or tune such fatal mechanisms. This truly offers a fascinating 
area for research in “designing and drug discovery”7-9 
In my PhD thesis work I have been involved in two projects exploring different fields of 
structural biology within the realm of “Metalloproteins” using both liquid and solid state 
NMR particularly exploiting NMR in the challenging cases, such as i) identification of hits 
to inhibit protein-protein interactions rather than inhibiting enzyme functions (using liquid-
state NMR) and ii) obtaining structural info on solid state proteins. 
Primarily my attention was devoted in screening small molecule inhibitors for S100 proteins 
(particularly S100B) with the aim of i) developing a rapid method to find effective inhibitors 
ii) explore their whole surface for possible docking positions comparable with the 
experimentally found binding sites and ii) check how analogous or different are the patterns 
of ligand binding sites for the two proteins. For this purpose we have chosen S100B and 
S100A131 as our target representatives for S100 protein family.  Our work results in an 
interesting finding, i.e. the presence of different binding sites in each S100 protein and of 
rather different behavior of different S100 proteins in spite of the fact that they are similar in 
structure. Besides, we have been able to find a variety of weak binding sites for a wide 
variety of ligands with little overlap of ligands for the two proteins. This finding is important 
because it shows that targeting protein-protein interactions may be intrinsically more 
difficult than targeting the active site of an enzyme but also that, for the same reason, the 
problem of finding selective binders for one or another member of a family of structurally 
related targets is much reduced or even abolished. It is also found that, given the abundance 
of weak binding sites on the surface of each S100 protein, the strategy to tether weak binding 
                                                 
1 The work related to S100A13 (both NMR and Docking) and the Docking work with S100B was done in 
collaboration with my colleagues Dr. Yvonne Arendt, Dr. Rebecca Delconte, Mattia Mori & Marco Porcu. 
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fragments to build a stronger inhibitor of a specific protein-protein interaction may be even 
more valuable than in the case of enzyme active sites (paper 1).  
Though solution-state NMR spectroscopy has been mostly used for studying protein-ligand 
complexes in solution, solid-state NMR too is now being used for such applications10-
12particularly for systems which cannot be studied by solution state NMR or even by X-ray 
crystallography due to the presence of technical difficulties. For example; large share of 
important pharmacological targets are insoluble membrane proteins10-12. Membrane proteins 
perform essential processes in the cell, such as controlling the flow of information and 
materials between cells and mediating activities like nerve impulses and hormone action. 
One-third of the genome of any organism encodes membrane proteins. But these systems 
cannot be studied in solution since they are highly insoluble. Moreover, possibility to study 
intimate dynamic information and electronic details for the bound ligands makes solid-state 
NMR13,14 a versatile tool for drug discovery and design. However, the pre-requisite of drug 
discovery is still the target identification/validation and protein structure determination by 
both liquid as well as by solid-state NMR. The evolution of several techniques for studying 
internuclear distances,15 anisotropy,16 torsion angles,17,18 atomic orientations,19,20 spin 
diffusions, molecular dynamics,21,22 exchange processes, Magic angle spinning (MAS),23-26 
resonance assignment,27,28 etc. assignment, etc has made Solid-state NMR an indispensable 
tool for chemical analysis and biomolecular structure determination. Recent studies 
demonstrated systems, particularly like insoluble aggregates such as amyloid fibrils,29-31 
membrane proteins32-36 can be purified or reconstituted in liposomes in functionally relevant 
states, can be studied by solid-state NMR spectroscopy in order to get structural information 
as well as in pharmaceutical aplications37. However, in spite of its various applicability, 
structure determination of biomolecules by high resolution solid state NMR is still 
problematic due to the difficulties in extracting structural restraints 38,39. Hence, this is an 
open field of high importance to develop new methods, strategies and experiments which can 
be useful for determining structural constraints. 
       Therefore in the second part of my work, I was involved in a project in which our target 
was to develop additional sources of structural restraints, through the analysis of the 
paramagnetic contribution in SSNMR of metalloproteins. In this part of my work we show 
how SSNMR paramagnetic restraints such as pseudocontact shifts (pcs) can be used as 
additional source of restraints for protein structural determination, even providing 
information about the relative arrangement of protein molecules in the solid phase. In a 
recent paper from our lab we reported the first observation of pseudocontact shifts (pcs) in 
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the 13C SSNMR of a paramagnetic protein, i.e. cobalt(II)-substituted matrix 
metalloproteinase 12 (CoMMP-12), and it was proposed that pcs could constitute additional 
structural restraints for SSNMR 40. From the known X-ray structure 41 we were able to show 
that the pcs observed for each of 246 different 13C assigned nuclei are very well accounted 
for by a sum of contributions arising from the intra-molecular cobalt(II) ion and from 
cobalt(II) ions belonging to neighboring molecules. It was concluded that if it were possible 
to separate intra- from inter-molecular pcs, even for cases where the structure was not 
available, intra-molecular pcs would constitute precious restraints to obtain the protein 
structure in the solid state. On the other side, inter-molecular pcs could provide information 
on the relative arrangement of different protein molecules in the crystal lattice. Addressing 
the latter point on microcrystalline samples of CoMMP-12, an approach which could be 
dubbed “NMR crystallography”42,43, could also be relevant for non-crystalline systems 
displaying one-dimensional order such as, for instance, protein fibrils. 
Here we show that using an approach based on the dilution of the paramagnetic species 44 in 
combination with two different labeling strategies it is effectively possible to experimentally 
separate intra- and inter-molecular pcs. Furthermore, we show that intra-molecular pcs do 
improve the quality of the structure in a computational simulation, and inter-molecular pcs 
provide quantitative information on the arrangement of the nearest protein neighbors. The 
present approach is general and independent from the information coming i.e. from X-ray 
diffraction techniques, so it could be applied also to ordered non-crystalline systems such as 
fibrils or amyloid proteins which bind metals (as prions)45. Even if the present method is 
demonstrated on a metalloprotein, it can be in principle extended to diamagnetic proteins 
once a paramagnetic metal is attached to them by using specifically designed tags 46,47. 
Finally we also demonstrate that use of paramagnetic shifts can provide us important 
structural restraints essentially reducing the number of distant restraints required for 
achieving a low resolution structure (paper III in preparation).  
        Parts I and II of this thesis are based on the following publications: 
Fragment docking to S100 proteins reveals a wide diversity of weak interaction sites. 
ChemMedChem. 2007; Yvonne Arendt, Anusarka Bhaumik, Rebecca Del Conte, Claudio 
Luchinat,* Mattia Mori,] and Marco Porcu. 
Paramagnetic Shifts in Solid-State NMR of Proteins to Elicit Structural Information 
Stéphane Balayssac, Ivano Bertini, Anusarka Bhaumik, Moreno Lelli, and Claudio 
Luchinat.(Under revision). 
Part III will constitute a third paper, presently in preparation. 
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1.1 Introduction 
One-third of all proteins are "metalloproteins",1 chemical combinations of protein atoms 
(carbon, nitrogen, oxygen, hydrogen, sulfur) with ions of various metals2-9. The metal ions in 
metalloproteins are critical to the protein's function, structure, or stability. In fact, numerous 
essential biological functions require metal ions, and most of these metal ion functions 
involve metalloproteins. Thus, metalloproteins make life on Earth possible. They enable us 
to understand and ultimately control the binding and activity of protein metal sites which is 
of great biological and medical importance. A relevant family of such metalloproteins is 
presented as Calcium binding proteins.10 This particular family of metalloproteins is 
comprised of several protein subfamilies depending on their structural and functional 
similarity such as: calmodulin-like subfamily, S100 proteins, neuron specific calcium 
sensors, calbindin D28k-like subfamily, parvalbumins, myosin light chains, calpain-like 
subfamily etc11. Interestingly, the members of calmodulin-like subfamily, S100 proteins, 
neuron specific calcium sensors and  myosin light chains are usually observed to have high 
affinity12,13 calcium binding domains and display large conformational changes14-17 upon 
calcium binding and participate in both modulation of Ca+2 signals and thereby playing 
regulatory role in cell. On the other hand, the protein members included in Parvalbumin, 
calbindin D28k-like subfamilies show high calcium affinity without any conformational 
change.  They may thus be responsible for structural stability and buffering intracellular Ca+2 
levels. 
1.2 S100 proteins 
1.2.1 General overview:  
        S100s are a unique group of calcium binding proteins characterized by cell-type and 
cell cycle- specific expression, as well as deregulated expression in neurological disorders 
(S100B- Alzheimer disease,18 Down syndrome,19 and epilepsy20), inflammatory disorders 
(S100A8/A9- cystic fibrosis,21 arthritis22 and chronic bronchitis23), and certain cancers 
(S100A2/A4/A6)24,25. They show a different extent of similarities; varying from 25-56% 
amino acid sequence identity, share conserved structural motifs and possibly common 
mechanisms of action. At the cellular level, S100 proteins have been implicated in the 
control of cell growth and proliferation, cell cycle progression, modulation of specific signal 
transduction pathways, transcription and differentiation24,26-29. They also have extra-cellular 
functions, including neurotrophic30 and antimicrobial activity31. A unique feature of these 
proteins is that individual members are localized in specific cellular compartments from 
which some are able to relocate upon Ca2+ activation, transducing the Ca2+ signal in a 
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temporal and spacial manner by interacting with different targets specific for each S100 
protein. The name is derived from the fact that the protein is 100% Soluble in ammonium 
sulfate at neutral pH.32 Twenty members have been identified so far in the human genome, 
and altogether, S100 proteins represent the largest subgroup in the calcium-binding EF-hand 
protein family. Because of its abundance in the nervous system and owing to the limited 
sensitivity of the immunological methods in earlier sixties,32 S100 was regarded as a brain 
specific protein restricted to glial cells. However, soon with the developments in different 
biochemical method and new discoveries indicated that the several members of this family 
were discovered to have various cellular distributions. S100 genes are expressed in many 
tissues including those of the nervous system, musculature, skin,33 adipose tissues, 
reproductive system, gastrointestinal system, respiratory system, and urinary system. 
 
1.2.2 Structural Overview:  
        S100 proteins are a type of homodimeric or heterodimeric low molecular weight protein 
found in vertebrates characterized by two calcium binding sites of the helix-loop-helix ("EF-
hand type")34 conformation. The term “EF-hand” was introduced by R. H. Kretsinger35 over 
30 years ago for the Ca2+-binding variant of a helix-loop-helix motif discovered in the 
structure of parvalbumin, a small Ca2+-binding protein isolated from carp muscle. The EF-
hand motifs were then identified in the amino acid sequence of troponin C, the myosin light 
chains, the ubiquitous calmodulin, and in many other Ca2+-binding proteins. Today, there 
are more than 3000 EF-hand related entries in the NCBI Reference Sequences Data Bank. 
The most common (canonical) EF-hand has a 12-residue Ca2+-binding loop that starts with 
an aspartate and ends with a glutamate.  
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The Ca2+–ligand geometry in small molecule-Ca2+ complexes is octahedral, which when 
applied to the Ca2+–EF-hand complex provides a convenient assignment of the ligands in 
the orthogonal coordinate system centered on the Ca2+, and the X,Y,Z axes defined by the 
first three Ca2+ ligands of the loop. However, in most EF-hand proteins Ca2+ is linked to 
seven oxygen atoms arranged in a pentagonal bipyramid. The Glu residue in the last position 
of the loop (−Z ligand) contributes two oxygen atoms of its γ-carboxyl group (a bidentate 
ligand). In all known structures of EF-hand proteins the central residue of the Ca2+-binding 
loop (the −Y position) binds Ca2+ with the main-chain carbonyl oxygen atom. Next to this 
residue, there is a hydrophobic amino acid (most frequently Ile, Val or Leu) that makes two 
hydrogen bonds with the equivalent residue of the paired EF-hand, a part of the short β-sheet 
connecting the two Ca
2+-binding loop. The composition and the length of the Ca2+-binding 
loops vary significantly among the EF-hand proteins.  The N-terminal EF-hand has a 14-
residue loop and except for the C-terminal glutamate, all protein ligands are the main-chain 
carbonyl oxygen atoms. Despite such radical departure from the “normal” mode of binding, 
the pentagonal bipyramid Ca2+-ligand geometry and the high affinity for Ca2+ are 
preserved. This variant of the EF-hand motif referred to as the pseudo EF-hand is found in 
members of the S100 protein family having lower Ca+2 affinity (KD = 200-500µM) than the 
other C-terminal EF hand motif (KD = 20-50µM)36. The key attribute of the regulatory EF-
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hand proteins is the ability to change their conformation upon binding Ca2+, thus acquiring 
different interactive properties. The structure of EF-hand I of calcyclin 
(S100A6)32,37determined by X-ray crystallography is very similar in the apo and in the 
Ca2+-bound states. In contrast, in EF-hand II, Ca2+ induces a large 86° change in the 
orientation of helix III with respect to helix IV. A similar Ca2+-dependent change in the 
orientation of helix III was also found in S100B. Based on the respective apo structures it 
most likely occurs also in S100A1 and S100A3. This reorientation of helix III results in the 
formation of a hydrophobic patch surrounded by a number of acidic residues in the S100 
dimer, which is proposed to function as the target recognition site. The exceptionally large 
change in the position of helix III is related, at least in part, to the “inverted” conformation of 
the Ca2+-binding loop II in the apo structure.  Interestingly it is observed38 that the 
molecular surface of S100B dimer is characterized by many charged residues, especially 
negatively charged ones, whereas no obvious hydrophobic surface has been reported in apo-
S100B. On the contrary, in analogy with calmodulin, the Ca+2 dependent conformational 
change exposes a buried hydrophobic core on the protein surface in the holo-S100B, 
indicating a novel mode of target recognition through hydrophobic interaction. 
1.2.3  S100 proteins as drug targets: 
        S100 proteins have received increasing attention due to their close association with 
several human diseases39 including Alzheimer's & down syndrome (S100B),19 
cardiomyopathy (S100A1), cancer (S100A2, S100A4, S100A6, S100A7, S100A11, 
S100P),39 Amiyotrophic lateral Sclerosis (ALS) (S100A6),40,41 psoriasis (S100A7),42 
Inflammation (S100A8/S100A9),43 rheumatoid arthritis (S100A12),44,45 neurodegenerative 
disorders and cancer. They have also been proven to be valuable in the diagnostic of these 
diseases, as predictive marker46,47 of improving clinical management, outcome and survival 
of patients and are considered as potential drug targets to improve therapies. Importantly, 
these proteins regulate intracellular processes such as cell growth and mobility, cell cycle 
regulation, transcription, and differentiation. This suggests that different S100s have 
different functions, and as they do not have any catalytic activity of their own it is likely that 
they regulate the activity of other proteins. Many of these regulatory pathways involve a 
direct interaction of a specific S100 protein with a particular target protein, so it is 
reasonable to expect that different members of the S100 family have quite different 
physiological roles. Misregulation of any of these interactions can thus cause pathologies, 
which make S100 proteins potential drug targets. For example; the role of S100B in 
proliferation has been demonstrated through its binding capability with the C terminus 
 26
regulatory domain of p53 and inhibiting its tumor suppressor function.48-52The comparison 
of three structures, calcium-free S100B (apo-S100B), calcium-bound S100B (holo-S100B), 
and holo-S100B bound to a peptide derived from the C-terminal negative regulatory domain 
of p53 proved to be very useful in understanding this role in a convincing manner.48,53,54 It 
has been reported that upon addition of calcium to apo-S100B, several hydrophobic residues 
on helix 3, helix 4, and loop 2 are exposed due to a large conformational change in the 
second EF-hand domain of S100B. These newly exposed residues form a small-hydrophobic 
patch on the surface of holo-S100B and participate in the S100B-p53 binding interface. In 
the absence of calcium, these same hydrophobic residues are buried in the core of an S100B 
subunit, and p53 cannot bind S100B, even at mM concentrations, thereby regulating wild 
type p53 tumor suppressor activity in cancer cells. Hence designing and search of small 
molecule inhibitors of this interaction could be of high importance.  
 
1.2.4 NMR in drug-screening 
NMR is one of several techniques to support drug discovery efforts.55-57 NMR screening is 
especially appreciated for its robustness of not producing false positive results, and for its 
sensitivity to identify weak interactions58-60. The primary, intrinsic advantage, of NMR is its 
ability to detect weak intermolecular interactions, e.g. between a ligand and a target. This 
ability makes NMR ideal for fragment-based screening61,62. In a fragment-based approach, 
comparably small and simple molecules are screened for binding to a target.  Frequently, 
NMR is used as a primary step to screen large numbers of such small molecules in a rapid 
and productive manner,63,64 to detect ligands that bind to a given target. Several NMR-based 
approach have been developed for this purpose. For example, Saturation-Transfer-Difference 
(STD) NMR spectroscopy,65-67 TINS (Target Immobilized NMR screening),68 Water-LOGSY 
experiments,69,70 screening using 2D 1H, 15N-heteronuclear single quantum coherence 
(HSQC) spectroscopy (often known as SAR by NMR),71,72 measurement of the translational 
diffusion rate73-75 using gradient-assisted NMR spectroscopy,76 and measurement of 
transverse relaxation rates (T2)77 of the ligand signals can be used to identify protein-ligand 
complex formation. Most of these methods are well established and documented for their 
ability to provide exclusive information on ligand binding. Among these experiments, STD 
experiments, TINS and water-LOGSY experiments are popular for large scale efficient 
screening. Both STD and water-LOGSY take advantage of the fact that the intermolecular 
NOE transfer is strongly negative. In STD NMR technique, a difference spectrum is 
generated from two spectra that are recorded with and without pre-irradiation of protein 
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resonances, whereby alteration of the population difference of the protein resonances is 
achieved by irradiation of regions of the protein 1H-NMR spectrum that do not contain 
resonances of the ligand. This technique is very sensitive, and can be used to determine the 
dissociation constant of the complex, either directly or in competition experiments. 
WaterLOGSY (water ligand observation by gradient spectroscopy) is a related experiment 
that is based on the transfer of magnetization from bulk water to the protein binding site and 
then onto a bound ligand. The success of both of these methods relies on their being based 
on 1D NMR experiments and on the modest requirement of target protein (5-10 µg)78. TINS 
(Target Immobilized NMR screening)68 is a comparatively recent method where binding of 
fragments to a protein is detected by comparing 1D NMR spectra of compound mixtures in 
the presence of a target immobilized on a solid support to a control sample. One of the 
advantages of this method is its applicability for soluble as well as membrane bound proteins 
which are usually difficult to get in soluble form. Moreover, a reference protein can be used 
in order to remove false positive signals due to weak, non-specific interactions between 
small molecules and proteins. However, this screening method requires a special hardware 
set up for its effective exploitation. All these above mentioned screening methods are well 
known for their ability for high-throughput screening and identification of small effective 
hits. Once such interacting compounds are identified, detailed structural insights about their 
binding properties are gained either from high-resolution NMR or X-ray crystallographic 
studies. At this point, computational methodologies79-84 can serve in a significant manner.  
One of the most employed computational programs is DOCK85-87. This method is 
particularly used in prediction of ligand conformation and orientation within a targeted 
binding site. It is helpful in understanding the protein-ligand interactions considering various 
factors implicated in this phenomenon, such as electrostatic interactions, van der Waals 
interactions, solvation or entropic effects88 along with the flexibility89 of ligand and 
protein90-92. Other than identification of potential ligands, this method is also applicable for 
further modification of identified weaker “leads” using computer-based modeling. Moreover, 
docking methods allow predicting the conformation of the binding site on a protein surface 
on the basis of accurate (known structure) or approximate shape and electrostatic 
complementarities. Based on this structural information, these compounds are modified to 
generate, in a cyclic process, molecules with high efficacy. However, it is widely appreciated 
that inhibiting specific protein-protein interaction is a more difficult objective than inhibiting 
for example, enzymatic functions, and this is the reason why much has not been achieved in 
this area. For example, the well-known families of matrix metalloproteinases (MMPs) are 
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enzymes with a well-defined catalytic role, whereas S100 proteins are in general, modulators 
of different protein activities. So the interaction site is very well defined in MMPs but yet 
largely undefined in S100 proteins. However, MMPs suffer from the problem that they have 
very similar structures and functions, and inhibiting a particular MMP selectively without 
affecting the other members of the family is difficult93,94. Conversely, the members of S100 
family have a variety of partners and therefore it may be hoped that selectivity is more easily 
achieved. 
           Therefore, in this study we decided to look at two different S100 proteins (S100B and 
S100A13) in order to i) explore their whole surface for possible docking positions and ii) 
check how analogous or different are the patterns of ligand binding sites for the two proteins. 
S100B is reported to interact with the C-terminal peptide of p53,48,49,54,95,96 and to be 
involved in cancer through the regulation of p53 protein,97-101 intrinsically known as a 
tumour suppressor factor. Moreover, for the S100B–p53 interaction, it was found that 
phosphorylation of specific serine and/or threonine residues reduce the affinity of the 
S100B–p53 interaction by as much as an order of magnitude, and are important for 
protecting p53 from S100B-dependent down-regulation.50 S100A13 has been recently 
designated as a new marker of angiogenesis in human astrocytic gliomas,102and as a 
regulator of the FGF-1 release103-105. 
 In the present work both S100 proteins were screened via NMR towards a fragment library 
(430 members). We found that a large variety of weak binding sites (low mM-high µm range) 
exist in the two proteins, with little overlap between the fragments that bind to one or the 
other protein. We have also found that in the case of S100B there are two main sites that are 
able to bind fragments of the library and are potentially overlapping with the interaction area 
of the p53 C-terminal peptide. Interestingly, S100A13 does not show appreciable affinity for 
these ligands, confirming our hypothesis that the variety of functions of S100 proteins may 
make it easier to find selective ligands for individual members of this family. This is a 
further step to attempt drug design strategies for these proteins. 
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1.3 Materials & methods 
1.3.1 Protein preparation: Human S100A13106 and bovine S100B107 were expressed and 
purified as previously reported to obtain unlabelled and 15N labelled proteins. 
1.3.2 Backbone assignment of both apo and holo S100B: This was done using the 
reported solution structure108 and 3D HSQC-NOESY, HNHA experiments and using 
previously reported assignments. All the NMR experiments were done with 0.65mM of 15N 
lebelled S100B, 30mM Hepes, 50mM KCl, pH-6.5 at 700MHz and 500MHz. 1H-15N HSQC 
spectrum was collected using the sensitivity-enhanced method. The number of complex data 
points and spectral widths were 512, 8000 Hz (1H) and 64, 1500 Hz (15N), respectively. 
15Nedited NOESY-HSQC spectra were recorded with mixing times of 50 and 150 ms. The 
number of complex data points collected and spectral widths were 512/7000.4 Hz F3 (1H), 
32/1500 Hz F2 (15N), and 128/7000.4 Hz F1 (1H). An HNHA experiment was acquired with 
512 F3 (1H), 64 F2 (15N), and 32 F1 (1H) complex data points. 
 
 
 
1.3.3 NMR-Based screening: For all the NMR experiments S100A13 samples were 
prepared in acetate buffer 20 mM pH 5.6, and S100B samples were prepared in HEPES 
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buffer 30 mM pH 6.5, KCl 50 mM. Samples for Water-LOGSY109 experiments were 
prepared at a monomeric concentration of 20 µM of both S100A13 and S100B, with 
candidate ligand concentrations of 800 µM .Samples for 15N-HSQC spectra were prepared at 
monomeric protein concentration of 100 µM and 400 µM for S100A13 and S100B, 
respectively. Concentration of the S100B was checked by UV spectroscopic detection using 
reported extinction coefficient €280 =3400M-1 cm-1. All NMR experiments were performed at 
298 K on a Bruker Avance 700 spectrometer equipped with a sample changer, and on Avance 
800 and 900 spectrometers both equipped with cryo-probes. NMR-based screening was 
conducted using   WaterLOGSY spectra as the primary method of screening. For each 
compound, a reference 1D spectrum of the compound alone and a 1D WaterLOGSY 
spectrum in the presence of the protein were recorded. WaterLOGSY NMR experiments 
employed a 2msec selective rectangular 180º pulse at the water signal frequency and a NOE 
mixing time of 2 s. To map the interacting surface of the proteins, titration of the fragments 
were followed through 15N-HSQC spectra. KD values were calculated by plotting the 
weighted average 1H and 15N chemical shifts of selected residues as a function of 
concentration of fragment added during the titration considering one site binding mode. 
Garrett values are given by equation 110 
 
                                                     
1.3.4 Docking: Docking calculations were performed on a Open Mosics cluster equipped 
with nine AMD Athlon 3.0 GHz processors running Gentoo Linux. The molecules were 
manipulated using ChemOffice Pro version 8.0. The atomic partial charges of the fragments 
were calculated using the semi empirical MNDO/3 and PM3 methods implemented in the 
Chem3D 8.0 program, whereas for the proteins S100A13 (PDB code: 1YUU) and S100B 
(PDB code: 1DT7) we assigned the atom types and the charges using AMBER force field. 
With the program AutoGrid we generated three grids of size 70M70M70 N and with a grid 
spacing of 0.375 N (three for S100A13 and one for S100B). The grid boxes was centered 
respectively: on the helix- α1, near the calcium (S100A13 GRID 1), on the two tryptophans 
77 of the helix-α4, at the interface between the two monomers (S100A13 GRID 2), on the 
hinge-loop (S100A13 GRID 3), and in the hydrophobic cluster between helices α3 and α4 
and hinge loop, close to the side chain of I47 (S100B GRID). The ligands were docked with 
the program AutoDock (version 3.05). For each docking experiment we performed a global 
search using the Lamarckian genetic algorithm (LGA) to find the possible areas of minimum 
energy of interaction and a local search (LS) to optimize the energy and to search for the best 
( )[ ] ( )[ ]
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conformers. During the docking process, a maximum of 100 conformers was considered for 
each compound (the default is ten conformers). The initial position of each ligand was on the 
center of the box and oriented randomly. The initial population was constituted by 100 
random individuals. Step sizes of 0.2 N for translation and 58 for rotation were chosen and a 
maximum number of 1500 000 energy evaluations and 28000 generations were considered. 
Operator weights for crossover, mutation, and elitism were default parameters (0.80, 0.02, 
and 1, respectively). The AutoDock scoring function was used and the first four clusters of 
solutions were furthermore analyzed one by one to check the agreement between the docking 
position on the surface and the experimental screening results. 
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1.4 Results & Discussion 
1.4.1 NMR-based screening and mapping of the binding sites 
1.4.1.1 WaterLOGSY-based screening: An NMR-based screening was conducted using the 
ligand-based waterLOGSY (water-ligand observed via gradient spectroscopy)109 technique 
on calcium-loaded S100A13 and S100B. In WaterLOGSY experiment (Water-Ligand 
Observed via Gradent SpectroscopY)109 the large bulk water magnetization is partially 
transferred via the protein-ligand complex to the free ligand in a selective manner. In this 
experiment, the resonances of non-binding compounds appear with opposite sign with 
respect to each other and tend to be weaker than those of the interacting ligands. In order to 
perform high throughput screening many of the experiments were done in presence of couple 
of ligands. Figure 2A (Results section) represents a 1H spectrum of (5B and 5C) a couple of 
inhibitors. In presence of protein molecule in the solution the interacting compound appears 
to be negative with respect to the non-interacting components (Figure 2B). 
 
    
 
        The fragment library of ProtEra S.r.l. was used, containing 430 commercially available  
fragments as chemically diverse as possible (see Table 1 and Figure 3).The library is small 
and generic, and was purposely built to also contain smaller than usual fragments. Fifty-six 
and forty-seven fragments showed an interaction with S100A13 and S100B, respectively. 
Only thirteen fragments bind both proteins. 
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Table 1. Characteristics of the fragment library
   Min value Max 
value 
Average 
value 
Molecular Weight 68 350 181.9 
Number of HEAVY 
atoms 
2 26 12.5 
Number of rings 0 5 1.4 
Ring size 3 7 5.8 
LogP -2.5 8.8 1.1 
ClogP -9.2 6.1 0.9 
H-bond donors 0 5 1,3 
H-bond acceptors 0 6 2,5 
 
The interaction mode of the fragments having significant effect in waterLOGSY, as well as 
of the anti-allergic drug cromolyn, known to interact with S100A13,111,112 were categorized, 
on the basis of their scaffold similarity, into 17 groups. Fragments belonging to the same 
group present similar chemical shift variation pattern. 
1.4.1.2 Chemical shift mapping For each group, at least one fragment was further 
investigated by following the titration of the proteins with the selected fragments through 
15N-HSQC spectra. The chemical shift perturbation (∆δ(NH) or Garrett values), of uniformly 
15N-labeled protein samples upon complex formation with a ligand provides a sensitive tool 
for the identification of binding sites. The 15N and NH backbone resonances in the ligand-
protein complexes were assigned by following the previously assigned cross peaks in the 
15N-HSQC spectrum of each S100 protein alone. The fragments of each group determine 
similar distributions of the chemical shift perturbation.   The interacting fragments and the 
areas of interaction with S100B and S100A13, with significant 15N-HSQC spectra 
perturbations (∆δ(NH) > 0.03 ppm), are reported in Table 3. A relatively small fraction of the 
compounds in Table 3 have M.W. smaller than 150, which is empirically considered to be a 
lower limit for “ideality” of a hit. For the present purposes, these less than ideal hits still 
provide useful information. Figures 4 and 5 represent the chemical shift variation of S10013 
and S100B while interacting with anti-allergic drug cromolyn and the ligand 1-naphtol (5B)  
respectively.  
A detailed analysis of Table 3 reveals that there are two main binding areas for ligands on 
S100B.  
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The first area involves the hinge loop and the C-terminal part of helix α4, the second area 
involves the hinge loop and helix α3 (Figure 7). On the other hand, in the case of S100A13 
three main binding areas can be identified i.e: (i) the second calcium binding site with the C-
terminal part of helix α1; (ii) the hinge loop region between helix α2 and helix α3, which  
extends to the C-terminal part of helix α4 and the N-terminal part of helix α1 of the second 
subunit; (iii) the interaction area between the two subunits, which could involve helix α4 
and/or helix α1 (Figure 8). For the ligands showing the largest effects in the waterLOGSY 
and HSQC experiments, KD values were calculated from chemical titrations and reported in 
Table 2. Figure 4 represents an example of ∆δ(NH) plot with variation of ligand cromolyn 
added to holo-S100A13. 
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Table2. KD and ligand efficiency (LE) values calculated for interesting hits for S100A13 
and S100B. 
Molecular 
formula 
Library 
code 
KD (mM) 
on 
S100A13 
KD (mM) 
on S100B 
Residues with ∆δ(NH)>0.03 ppm 
 
 
5B - ~0.1 
LE=0.50 
8,11,16,42,43,45, 47,48,51,53,61,70,79,87 
 
19V - ~1.5 
LE=0.38 
4,5,9-12,25,43,59, 75,77,79,82, 
84-89 
 
2T - ~2.3 
LE=0.26 
1,4,8,9,11,16,18, 41-43,54,55,58, 
61,75,80,82,84, 88-90 
 
AC - ~1.0 
LE=0.20 
8,-10,19,35,37,42, 43,48,62,71,73,75,76,79-81,83-85, 
87-91 
HO OH  
4E 
~0.9 
LE=0.24 
- 49, 50, 52, 53, 54, 82 
 
9A ~0.9 
LE=0.35 
- 2, 6-8, 11, 12, 14, 18, 24, 25, 34, 38, 43, 49, 56, 65, 
73, 74, 77, 78, 81, 85, 87, 89 
  12Z ~1.8 
LE=0.42 
- 7, 8, 11, 12, 14, 18, 24, 25, 30, 34, 40, 64, 65, 78, 80 -
82, 84, 89 
HO
O
NH2
OH
O
 
13Y 
~2.3 
LE=0.43 
- 
4, 7, 8, 11, 12, 14, 18, 24-26 , 34, 43, 48, 50 ,83, 86, 
87, 89, 92,  
 
21M ~0.7 
LE=0.19 
- 6, 11 18, 20, 22, 71, 73, 74,77, 78, 81-84, 86, 89, 93 
cromolyn ~0.3 
LE=0.14 
- 16, 18, 21, 50, 64, 65, 71 73, 77, 80, 81, 82, 84, 86, 
89, 92 
 
From the knowledge of the KD we calculated the ligand efficiency (LE) of each fragment, 
defined as: 
 
LE=-∆G/Nnon-hydrogen atoms≈-RTln(KD)/ Nnon-hydrogen atoms            (1) 
 
The concept of ligand efficiency, introduced by the pioneering work of Kuntz, Kollman and 
colleagues, can be used to assess the quality of initial screening hits and also the quality of 
the leads as they are optimized61,113. LE values higher than 0,3 are considered a good starting 
point for the hit-to-lead development process. Our results showed that two ligands for S100B 
and three ligands for S100A13, have LE values higher than 0.3. These ligands should be then 
a good starting point to develop protein ligands with high druggability potential. 
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   To identify the binding conformation of the hits, we coupled the experimental NMR data 
with docking calculations, using AutoDock program, as recently reported by Mercier K.A. et 
al 
 
1.4.2 S100A13 
1.4.2.1 Docking: Docking calculations were carried out to identify the more probable 
binding conformations for each of the twenty four ligands with non-negligible chemical shift 
variations (∆δ > 0.03 ppm, Table 3) 
  The docking calculations were performed on three different potential grid maps, covering 
the entire protein volume, centered on the three binding areas identified by the NMR 
screening (The docking protocol is described in the experimental section). The analyses were 
performed manually, taking into account both the agreement with the NMR data and the free 
binding energy of the ligand-protein complex provided by the docking results. The docking 
results are consistent with the presence of three main binding areas on the protein S100A13. 
In particular compounds warfarin (21M), anthraquinone-sulfonic acid (3S), 2,6-
naphtalenedisulphonic acid (11B), 3,5-pyrazoledicarboxylic acid (11L), benzothiophene 
(12Z), and furosemide (17K) preferentially interact in area i), compound 2,3-
dicarboxypyridine (9A) preferentially interact in area ii) and the compounds bisphenol A 
(4E), cimetidine (17C), (L)-glutamic acid (13Y) preferentially interact in area iii). For each 
of the ligands we found at least one cluster of docking conformations in agreement with the 
area identified by the NMR experiments. 
 
1.4.2.2 Cromolyn binding. In 1997 and 1999 Kobayashi et al.111,112 demonstrated that three 
different anti-allergic drugs, among which cromolyn, bind to S100A13. To investigate the 
molecular basis of this interaction, we performed a 15N-HSQC titration of S100A13 with 
cromolyn. Plots of δ∆(HN) vs ligand concentration for the most shifted residues (T18, F21, 
V65, A84 and K89) give a good fitting with the one binding site equation (R2≈0.97). 
Docking calculations generated two clusters of conformations, in agreement with the 
experimental data, binding in the areas A and C of Fig. 5 respectively; however the cluster 
interacting near the helices α4 (area C of Fig. 5) is characterized by a final docked energy 
thirty percent lower with respect to the others; in this solution cromolyn is close to many of 
the residues with high chemical shift variation, in particular V65 of loop III, W77, and E82 
of helix α4 (Figure 5C). Our data thus provide a structural basis for this interaction. 
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1.4.3 S100B  
1.4.3.1 Docking. All the fragments interacting with S100B by waterLOGSY experiments 
were docked on the surface of the S100B protein and, as for S100A13, the docking solutions 
were analyzed manually, according to the agreement with the HSQC data and the free 
binding energy of the ligand-protein complex. Two possible interaction areas have been 
identified, located around the hinge loop. In particular, the first one is characterized by the 
pocket involving the hinge loop, helix α1 and mostly the C-terminal portion of helix α4 
(F87, C84, F43, L44, and V8) (see Figure 6B & C). Compounds (L)-tryptophan-methylester 
(16G), 1,10-phenantroline (2T), (3R,9R)-3-((benzyloxy)methyl)-hexahydro-6H-
pyrido[1,2]pyrazine-1,4-dione (AC) preferentially interact in this surface region, justifying 
the chemical shift variations observed especially in the first part of helix α1. Also the second 
interacting area involves the hinge loop, but also involves the helix α3 in its N-terminal part. 
The compounds showing significant interactions in the second area are 1-naphtol (5B), 2-
aminobenzimidazole (19V), (3R, 9R)-3-((benzyloxy)methyl-hexahydro-6H-
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pyrido[1,2]pyrazine-1,4-dione (AC). These interactions are responsible for the largest 
chemical shift variations observed in helix α2 and helix α3. 
  By the analysis of the docking results most of the fragments bind exclusively in one of the 
two areas identified. In a fragment based approach the identified fragments binding in 
different areas should be subsequently linked with the intent to obtain stronger interacting 
compounds for S100B. 
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1.4.3.2 Competition with p53. In order to check the potential of fragment 5B (1-naphtol), 
interacting with the p53 binding region of S100B, 15N-HSQC titration was performed in the 
presence of a peptide, known to interact with S100B, derived from the C-terminal regulatory 
domain of p53 (residues 367-388). Figure 9 represents the superimposition of 15N HSQC of 
holoS100B (red) and holo-S100B titrated with p53 peptide up to 1:2 molar ratios. 
Apparently chemical shift changes were observed for most of the residues as reported 
before49,96. Compound 5B was chosen due to its lowest KDvalue observed for the interacting 
fragments. The p53 peptide affects several peaks (especially in helix α1, hinge region, helix 
α3, helix α4 and C-terminal region) in a 15N-HSQC titration on the protein; 5B alone affects 
several peaks already described, some of which are in common with p53 peptide. 15N 
labelled S100B was first titrated with p53 peptide up to 1:2 molar ratio with respect to the 
S100B monomer, and 5B was added stepwise up to a molar ratio of 1:2:4 respectively. 
Further addition of 5B resulted in the precipitation of the protein. Comparing the four spectra 
of i) S100B:5B; 1:2 ii) S100B:p53 peptide; 1:2 iii) S100B:p53 peptide: 5B; 1:2:2 iv) 
S100B:p53 peptide:5B; 1:2:4, we observed that the addition of the 5B fragment to the 
S100B-p53 peptide complex has different effects on different peaks: several of them are 
restored to the original position in the S100B-5B adduct (see Figure 10A ,B,C & D). Most of 
these peaks are located on the helix α3, in the proximity of the hinge loop (Q51, V52, V53, 
D54, K55, V56, and M57). Some other peaks were shifted to a new position (L10, H15, 
G19, S30, E31, E34, N38, S62, D63, G66, E67, D69, F73, M74, and F88) different from 
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their original positions in S100B-5B and S100B-p53 peptide adducts. This points to 5B 
replacing a portion of the bound peptide molecule, with a mixed competitive/non 
competitive behaviour. The other portion of the peptide presumably re-arranges in a new 
conformation to avoid conflict with the surface portion occupied by 5B. The peaks that are 
restored clearly identify the region of the protein where 5B binds, displacing a portion of the 
peptide  
 
Figure 9: Superimposition of 15N HSQC spectra of holo-S100B (red) and holo-
S100B titrated with p53 peptide (blue) up to 1:2 molar ratios 
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Table 3 – For each group the investigated Interacting fragments, showing non-negligible 
15N-HSQC spectra perturbations, are reported.  The areas of interaction with S100B and/or 
S100A13 are also indicated.  
 
Fragment 
interacting with 
protein 
Group 
S100B S100A13 
Fragment formula (MW/Da) 
Residues showing 
non-negligible 
chemical shift 
variation: 
a) 0.03<∆δ<0.
08 ppm 
b) ∆δ>0.08  
ppm 
 19L 
4-Hydroxycoumarin (162.14) 
 
 
 
                    
a) 
18,74,77,78,82,84,89 
b) - 
 21B 
Dicoumarin (336.29) 
a) 
18,20,21,22,25,31,72
,82,83 
b) - 
 21M 
Warfarin 
(308.33) 
a) 
6,11,18,20,22,71,73,
78,81,83, 
84,86,89,93 
b) 74,77,82 
A 
 Cromolyn 
Cromolyn (512.33) 
 
 
 
 
 
a) 
16,21,50,64,71,73,81
,86,92 
b) 
18,65,77,80,82,84,89
, 
O
OHOOC
O O
OH
O
O COO H
O
OH
O
HO
O
O
HO
O
O
O
HO
O
O
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B  3S 
Anthraquinone-2-sulfonic acid Sodium Salt 
(310.26) 
a) 
4,12,14,15,20,23,24,
25,29,33, 
34,41,49,50,53,60,61
,64,66,68, 
69,70,71,74,80,82,85
,89,92 
b) 
6,16,21,22,31,40,65,
77,78,81, 83,84,86 
5B  
1-Naphtol  (144.17) 
a) 
8,11,16,42,43,45,47,
48,51,53, 70,79,87 
b) 61 
C 
 11B 
2,6-Naphtalenedisulfonic (332.26) 
a) 
14,16,17,29,50,65,77
,80,82, 86,89 
b) 40,74,78,81,84,85 
D  4E 
Bisphenol (228.29) 
a) 49,50,52,53,54,82 
b) - 
E  17C 
Cimetidine (252.34) 
a) 
7,24,30,41,48,49,93 
b) - 
OHHO
O
O
S
O-
O
O
Na+
S
S
O
O
O-
-O O
O
Na+
Na+
OH
NHN
S
N
H
N
HN N
 44
F  13Y 
(L)-Glutamic Acid (147.13) 
a) 
4,7,8,11,12,14,18,25,
26,34,43, 
48,50,83,86,87,89,92 
b) 24 
G  11L 
3,5-Pyrazoledicarboxylic acid 
monohydrate (174.11) 
a) 
6,7,9,11,12,14,18,22,
25,26,30, 
34,37,39,41,43,49,50
,57,73,77, 
81,83,86,87,89 
b) 8,24,64,74,85 
 12Z 
Benzotiophene (134.20) a) 
7,8,11,12,14,18,24,2
5,30,34, 
40,64,65,78,80,81,82
,84,89 
b) - 
H 
16G  
(L)-Tryptophan-ethylester 
(248.32) a) 
10,18,42,44,47,74,79
,85 
b) - 
 16V 
(1R,2S)-(-)-N-methylephedrine (179.26) 
a) 18,24,80,93 
b) - 
I 
 9A 
2,3-dicarboxypyridine 
(167.12) a) 2,6-
8,11,12,14,18,25,34,
43,49, 
56,65,73,77,78,81,87 
b) 24,38,74,85,89 
HO OH
O O
NH2
HN N
OHHO
OO H2O
S
OO
N
H
H2N H
N
OH
O
N
HO
O
OH
 45
J  17K 
Furosemide (330.74) 
a) 
18,19,21,64,74,82,84
,86,89  
b) - 
K 19V  
2-Aminobenzimidazole (133.15) 
a) 4,5,10-
12,25,43,59,75,77,79
, 85-89 
b) 9,82,84 
L 2T  
1,10-Phenantroline (180.20) a) 
1,4,8,9,11,16,18,41-
43,54,55, 
58,61,75,80,82,84,88
-90 
b) - 
M 20D  
Julolidine 
(173.25) 
 
 
 
 
 
a) 42 
b) - 
N 20Y   
Tritylamine (259.34) 
 
 
 
 
 
 
a) 42 
b) - 
O 18Q  
1,2-dihydro-4-hydroxy-1-methyl-2-
oxoquinoline-3-carbaldehyde (203.19) 
a) 1,18,69,79 
b) - 
S
O
O
NH2HN
Cl
HO
O
O
N
H
N
NH2
NN
N O
OH
O
N
NH2
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P AC  
(3R,9R)-3-((benzyloxy)methyl)-hexahydro-
6H-pyrido[1,2]pyrazine-1,4-dione (288.34) a) 8-
10,19,35,37,42,43,48
,62,71, 
73,75,76,79,80,83-
85,87-91 
b) 81 
Q 20X  
(1S)-(+)-Neomenthyl acetate (198.30) 
a) 44 
b) - 
  
 
 
 
 
 
 
O
O
N
HN
O
O
O
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Figure 11. A summary of the hits for S100A13 and S100B obtained in the present work as 
compound with those obtainined on cytochrome c114 is reported. The relatively small hit 
overlap for the various proteins can be appreciated. 
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1.5 Conclusion 
Two S100 proteins with a potential to become drug targets were screened via NMR with a 
library of 430 fragments. The results of this study allowed us to identify three main binding 
areas for S100A13 and two main binding areas for S100B. This result is somewhat 
surprising, as small proteins usually display only one major binding site for small 
molecules.115 Incidentally, none of the binding areas suggest binding of ligands to the 
calcium ions. Although the two proteins have quite similar quaternary structure and a 
common binding area (around the hinge loop), our results showed that they have only few 
ligands in common, suggesting that selective leads could be developed starting from the 
different ligands, with high LE values, here identified. These data also indicate that the 
present library, although small, is well suited to make initial guesses about selectivity. 
Essentially the same library had been used in a screening work on cytochrome c114. In that 
case, the hits were fewer, and again the overlap with the present hits was very small. These 
statistics are summarized in Figure 11. Coupling of the experimental data with docking 
results indicated the most probable docked conformations of the ligands on the proteins 
surface. The study on the anti-allergic drug cromolyn provided for the first time structural 
information for the interaction, and demonstrated that cromolyn has a unique binding site on 
the protein surface. Finally, competition experiments conducted with α-naphtol on the 
S100B-p53 peptide complex showed that even if the ligands identified by the NMR 
screening bind weakly on the protein surface, they are able to significantly interfere with the 
interaction with other proteins or peptides. These results could be a starting point for the 
development of new ligands which could have an important role in the protection of p53 
from S100B-dependent down-regulation. S100 proteins in general are becoming targets of 
pharmaceuticals interest because of their involvement in cellular functions. The present data 
suggest that selective and high efficacy modulators of their activity are within reach of 
current lead development strategies. 
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2.1 Introduction 
                  Structural biology over the past decades has taken different directions and has 
become one discipline available to biomedical research. It allows crucial insights in 
understanding basic life processes such as protein-protein interactions1-4 signal 
transduction5,6 function of enzymes7 and action modes of drugs8 The indispensable 
prerequisite for understanding all this mechanisms is the structure of a protein involved. 
Both X-ray and liquid-state NMR have made it possible to obtain three-dimensional 
structural information at high resolution. Despite of their successful exploitation in 
determining protein structures, both of these techniques have their limitations in structural 
exploration of certain biomolecular systems which cannot be crystallised properly or be 
obtained in soluble form, such as membrane proteins and amyloid fibrils. Solid-state NMR 
(SSNMR) has emerged as a vital tool in Structural Biology. Recent studies have increased 
interest in this technique based on its ability to determine protein structures in the solid-
phase9 and to permit the study of macroscopically disordered biomolecular systems such as 
membrane proteins10,11 fibrils12-17 and macromolecular assemblies5-7. Despite of its several 
advantages, the major limitations in the structural determination through SSNMR are due to 
the difficulties in obtaining a large number of restraints to be used for structural 
purposes18,19. As a consequence several strategies18,20,21 and experimental techniques18,22,23 
have been developed. However, implementation of a systematic and strategically established 
protocol for solid-state structure determination is still the largest challenge in this field. The 
key difference of solid-state NMR with solution state is the presence of static or slow 
tumbling of component molecules in the sample. Solution NMR methods rely on rapid 
tumbling to average orientation-dependent dipolar and chemical shift interactions resulting 
in narrow resonances. On the contrary, such interactions are not averaged in solid-state NMR 
and thereby broad NMR resonances with low resolution and sensitivity are obtained. This in 
turn hinders the feasibility of solid-state NMR studies of uniformly (13C, 15N) labeled protein 
samples. This isotope labeling is a critical requirement for the applicability of NMR 
techniques in order to allow sequence specific resonance assignment24,25 and to extract 
structural restraints26-28. Hence, suitable methods for obtaining well-resolved solid-state 
NMR spectra are of high importance. Magic angle spinning (MAS) at this point has been 
successfully exploited both in terms of resolution and sensitivity of the spectra. Specific 
labeling pattern9 could also be highly effective for gaining well resolved solid-state spectra. 
These special labeling schemes offers several advantages: i) reducing the overlap in the 
PDSD spectra at higher mixing time deleting the cross peaks of adjacent carbon atoms 
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(which does not provide any structural information), ii) reducing the “dipolar truncation” 
effect making it possible to observe direct PDSD transfer up to 7Å, iii) improving the signal 
resolution by suppression of the C-C scalar J-coupling. On these samples, the cross-peaks 
observed in PDSD spectra at variable mixing time (up to 500 ms) allows one to establish 
nuclear distance correspondence from 2 to 7 Å, which are precious for the structural 
determination. These methods have been successfully applied for structure determination of 
proteins in the size range of 5-10kDa25,29,30. Expanding these applications to larger or mass-
limited systems needs further improvements in spectral sensitivity and new strategies to 
extract useful structural restraints. For this purpose, we have designed a simple and fast 
strategy to extract useful paramagnetic based structural restraints in terms of pseudo contact 
shifts (pcs) of 13C using a uniformly labeled sample. In this work we demonstrate a novel 
strategy by using paramagnetic probe in solid-state sample for extracting useful structural 
restraints for a larger system (17.5kDa protein). 
2.2 Paramagnetic metalloproteins Paramagnetic metalloproteins are characterized by the 
presence of unpaired electrons in the metal centre. An unpaired electron has a magnetic 
moment 658 times larger than that of the proton and has a relaxation time varying from 10-
13-10-8 s mainly depending on the electronic configuration. Electron relaxation generates 
stochastic magnetic fields. The electron magnetic moment can interact with the NMR 
sensitive nucleus giving rise to the so called hyperfine shift, composed by a scalar term 
called Fermi contact shift (δcon)31 and a dipolar term called pseudocontact shift (δpcs). The 
paramagnetism caused by the unpaired electron has a strong effect on the nuclei close to the 
metal centre, thereby resulting in extreme line broadening and very large hyperfine shifts. 
The contact contribution arises from electron delocalisation through chemical bonds. As an 
additional aspect, since the electron magnetic moment is endowed with sizeable anisotropy, 
the dipolar coupling with the nuclear spin magnetic moment does not average to zero upon 
rotation. This nonzero average of the dipolar coupling energy produces the pseudocontact 
shift (δpcs). This dipolar interaction by the long-range electron-nuclear dipolar interaction is 
directly related to the position of the observed nuclei with respect to the metal centre and the 
orientation of the principal axes of the anisotropy of the magnetic susceptibility. The δpcs 
values are given by Equation (1), where r is the distance between the observed nuclei and the 
metal ion, and ∆χax and ∆χrh are the axial and rhombic anisotropy parameters of the 
magnetic susceptibility tensor of the metal, as defined by  
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and θ and φ identify the polar coordinates of the nucleus in the frame of the electronic 
magnetic susceptibility tensor. These pcs values can be of high importance. Several reports 
have demonstrated a successful use of these pcs as structural constraints32-34. This led to 
designing an optimised protocol41 for solution structure and to include these restraints in the 
most popular software packages for solution structure determination such as 
DYANA/CYANA35 and Xplore NIH36. However, by using only pcs from one metal, one 
cannot get enough structural restraints to fold a protein35 structure otherwise, this becomes 
possible when several sets of pcs coming from different metals on the same protein are 
combined together,37 and using pcs together with other structural restraints as dihedral angles 
(determined in solution NMR from chemical shift indices or J-coupling constants) or 
distance restraints (for example from NOE measurements or H-bonds) In this case, pcs act as 
additional structural restraints allowing to obtain a significant refinement of the NMR 
protein structure especially as far as concern the determination of the metal position and the 
region around metal are concerned.38 
        In addition to the contributions to the NMR shift the paramagnetic interaction also 
affects the relaxation property of the observed nuclei, increasing both longitudinal and 
transverse relaxation rates (paramagnetic relaxation enhancement, PRE). For metalloproteins 
in solution, PRE originates from two mechanisms, the dipolar (equation 2) and Curie 
relaxation (equation 3).  
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In large metalloproteins and in sufficiently high magnetic field the Curie term becomes the 
dominant one as it is proportional to molecular tumbling and molecular weight of the species 
and also directly proportional to the square of B0 (magnetic field). The effect of R2curie causes 
dramatic line broadening beyond detection. The Curie broadening equation can written as 
equation 3 
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where, µ0 is the permeability of a vacuum, ge  is the electron Landè factor, µB is the Bohr magneton, is the 
Boltzmann constant, kT is the absolute temperature, is the external magnetic field, Iγ is the nuclear 
magnetogyric ratio, is the electron-spin angular momentum, τc is the rotational correlation time (in absence of 
exchange), ωI is the nuclear Larmor frequency and r is the metal-nucleus distance 
However this problem can be overcome and significant improvement can be achieved by 
using sequences based on 13C detection instead of 1H detection experiments. As the γI of 13C 
is 4 times smaller than 1H, hence the relaxation terms can be expected to be 16 times weaker. 
Moreover, Curie relaxation mechanism is related to the rotational correlation time (τc) so this 
contribution to line broadening is completely absent in the SS NMR as in solid phase 
molecular tumbling is prevented. Thus observation of solid-state NMR signal strongly 
benefit from the absence of Curie relaxation mechanism as well as any diamagnetic 
relaxation mechanism related to τc...Furthermore it takes advantages from 13C detection 
which in SS NMR offer a stronger resolution than 1H spectra.  
These aforesaid perspectives particularly stimulated us to investigate paramagnetic 
metalloproteins using solid-state NMR which has not been explored in biomolecules to date. 
The aim was to develop a simple strategy to extract paramagnetic restraints and to 
investigate the feasibility of those constraints in structural determination. In a recent paper 
from our group the first observation of pseudocontact shifts (pcs) in the 13C solid state NMR 
of a paramagnetic protein, i.e. cobalt(II)-substituted matrix metalloproteinase 12 (CoMMP-
12), was reported. The authors proposed pcs as additional structural restraints for SSNMR39 
From the known X-ray structure 40 it was shown that the pcs observed for each of 246 
different 13C nuclei are very well accounted for by a sum of contributions arising from the 
intra-molecular cobalt(II) ion and from cobalt(II) ions belonging to neighboring molecules. 
It was concluded that if it were possible to separate intra- from inter-molecular pcs, even for 
cases where the structure was not available, intra-molecular pcs would constitute precious 
restraints to obtain the protein structure in the solid state. On the other hand, inter-molecular 
pcs could provide information on the relative arrangement of different protein molecules in 
the crystal lattice. Addressing the latter point on microcrystalline samples of CoMMP-12, an 
approach which could be dubbed “NMR crystallography”41,42 could also be relevant for non-
crystalline systems displaying one-dimensional order such as, for instance, protein fibrils. 
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In my work, I show a combined strategy of protein labelling and dilution of the paramagnetic 
species43 which allows one to easily separate the pcs contribution originated by the protein 
internal metal (intra-molecular pcs) from those due to the neighbouring proteins in the 
crystal lattice (inter-molecular pcs). The inter-molecular pcs provide unique information on 
the protein arrangement in the solid phase, fixing position and orientation of the 
neighbouring proteins. The results are in good agreement with X-ray data. This sort of 
“NMR crystallography” is uniquely based on the paramagnetic solid-state NMR data and can 
be applied also to ordered non-crystalline systems such as fibrils, providing useful 
information on their aggregation state. As a continuation, we have tried to extend this work 
with the aim of determining the solid-state structure of ZnMMP12 protein using pcs as 
structural restraints along with a limited number of experimentally achieved distance 
restraints and torsion angle restraints. PCS can be obtained simply by comparing the 
paramagnetic and diamagnetic assignment. Torsion angle restraints were calculated on the 
basis of the diamagnetic chemical shifts of the heteronuclei N, Cα, C’, and Cβ by using the –
chemical Shift Index analysis (CSI44or TALOS45) program In particular pcs’s provides 
hundreds of restraints, as potentially we have one restraints for every assigned nuclei. Their 
impact in the structural calculation allowed us to strongly reduce the number of distance 
restraints that must be used. We demonstrated in a simulated calculation, that only 21 
distance restraints can be used to obtain a low resolution protein structure. In our strategy, 
this limited number of distance restraints can be obtained experimentally as well. To obtain 
these restraints a series of PDSD46 and CHHC47 spectra with varying mixing time acquired 
and analysed. As only few distance restraints are required, we propose to determine them 
from the spectra obtained on the uniformly labelled ZnMMP-12 sample referring to the more 
resolved region of the spectra. These distance restraints were then used along with intra 
molecular pcs and CSI calculated torsion angle constraints to get a fairly resolved low 
resolution structure of the ZnMMP12 (RMSD 2.33Å w.r.t the X-ray secondary structure ).  
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2.3 Materials and Methods 
2.3.1 Preparation of the microcrystalline diluted samples. The ZnMMP-12 protein was 
expressed following the already published procedure40. The CoMMP-12 sample with the 
strong NNGH inhibitor (NNGH = N-isobutyl-N-[4-methoxyphenylsulphonyl]glycyl 
hydroxamic acid) was obtained by replacing the Zn2+ ion with Co2+ in the ZnMMP-12 
protein following the procedure published elsewhere48 and using 1 mM Co2+ solution instead 
of 0.3 mM.  
The diluted CoMMP-12 sample was obtained by mixing a solution containing 15 mg of 13C-
15N labeled CoMMP-12 with a solution containing 30 mg of unlabeled ZnMMP-12 protein 
(45 mg overall). The amount of protein was chosen in order to obtain around 35-40 mg of 
microcrystalline material. The diluted ZnMMP-12 sample was obtained by mixing a solution 
containing 15 mg of 13C-15N labeled ZnMMP-12 with a solution containing 30 mg of 
unlabeled CoMMP-12 (45 mg overall), in order to obtain around 35-40 mg of 
microcrystalline material. 
The two sample mixtures were crystallized with the sitting drop vapor diffusion method at 
16 °C, using a micro-seeding tool, in a handmade crystallizer. Aliquots of 50 µl of 1.5 mM 
protein solution (10 mM Tris/5 mM CaCl2/1 mM CoCl2/300 mM NaCl/3 mM NNGH, 
pH=7.0) were mixed with 50 µl of reservoir buffer (0.1 M Tris·HCl/25% PEG 8000, pH=8.3) 
and all equilibrated against 250 ml of reservoir buffer. The final protein concentration was 30 
mg/ml. The first crystals appeared within 2 days, and continued to grow regularly up to 2.5-3 
weeks. The microcrystals thus obtained were washed using 50 µl of a low-salt buffer (10 
mM Tris·HCl/25% PEG 8000 pH=8) for 1 hour. Approximately 35-40 mg of these crystals 
were transferred in a 50 µl ZrO2 HR MAS rotor, and sealed with the upper spacer in order to 
maintain the amount of water constant. 
2.3.2 Solid-State NMR spectroscopy. All the NMR spectra were recorded on a Bruker 
Avance 700 wide bore instrument operating at 16.4 T (700 MHz 1H Larmor frequency, 176.0 
MHz 13C Larmor frequency). A double/triple-channel 4mm CP-MAS probehead was used. 
The spinning frequency of the ZrO2 HR MAS rotor was stabilized to ±2 Hz. Solid-state 
chemical shifts are referred to DSS following the procedure reported in literature49. The 
probe temperature was kept at a nominal temperature of 270 K, which ensures a sample 
temperature around 280 K. 
In double resonance CP experiments the 1H 90° pulse was set to 3.2 µs, and during cross-
polarization the 1H B1 was 64 kHz with a mixing time of 0.75 ms. A 100%/50% ramp was 
applied on the carbon channel with a 100% power level of 74 kHz. Similar parameters were 
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also used for a standard proton-driven spin diffusion sequence (2D PDSD); the 13C 90° pulse 
was 4.2 µs, and the mixing times were set to 60 ms for the fully labeled CoMMP-12, the 
diluted CoMMP-12, and the diluted ZnMMP-12. The MAS frequency was varied from 8.5 to 
11.5 kHz. The SPINAL-6450 decoupling at 72 kHz of power was used on proton for all the 
samples, switching off the decoupling during the mixing time. The conditions used to 
acquire the PDSD of the fully labeled ZnMMP-12 sample were reported before  
The triple resonance 3D NCACX PDSD and 3D NCOCX PDSD experiments were acquired 
on the full-labeled CoMMP-12 sample using the standard sequences. The 13C 90° pulse was 
5.2 µs. The HN Hartmann-Hahn matching was optimized with a 1H 90° pulse of 3.1 µs, 35 
kHz for the 15N B1 and a 100%/50% ramp on the 1H channel applied for 1.7 ms at 68 kHz. 
The NC matching was optimized using the 15N B1 of 35 kHz and a Tangent Amplitude 
Modulated ramp at 23.5 kHz on 13C. The NC matching was 6.25 ms long using a 
simultaneous 1H CW decoupling of 108 kHz. SPINAL64 1H decoupling at 81 kHz was used 
during the direct and indirect acquisition times. A weak 1H CW radio frequency optimized at 
11 kHz (DARR) was used during the PDSD mixing time (45ms for NCACX and 60ms for 
NCOCX). Both NCACX and NCOCX experiments were recorded at 11 kHz MAS 
frequency, with 64 scans per experiment, 1228 direct points, 64 increments in the indirect 
13C dimension and 20 increments in the indirect 15N dimension using the TPPI scheme for 
both indirect dimensions. 
Similar parameters were also used for a standard proton-driven spin diffusion sequence (2D 
PDSD); the 13C 90° pulse was 3.5 µs, and the mixing times were varied from 5 to 120 ms. 
The MAS frequency was varied from 8.5 to 11.5 kHz. The SPINAL-6450 decoupling at 83 
kHz of power was used on proton, switching off the decoupling during the mixing time. All 
the experiments were acquired with 32 scans per experiment, with 1024 direct points, and 
704 experiments in the State-TPPI scheme. 
The CHHC experiments were acquired using the sequence reported in literature,47 1H 90° 
pulse was set to 2.4 µs, and 13C 90° pulse was set to 3.9 µs. During HC and CH CP 88 kHz 
on 1H and 70 kHz spin-lock power 13C were used using 50-100 ramp on 1H. In the first (non-
selective) CP was 550 µs long were the single CH and CH selective CP transfer were 70 µs 
long each. 4ms were used during the z-filter block and the mixing time was varied from 60 
to 300 µs. The SPINAL-6450 decoupling at 93 kHz of power was used on proton during both 
direct and indirect evolution periods. The 2D experiment was acquired using the States-TPPI 
scheme, using 192 scans for experiment, 12 ms of direct acquisition time and 6 ms of 
indirect acquisition time. 
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2D PDSD spectra were processed using zero-filling up to 4096 points in the direct 
dimension and 2048 points in the indirect dimensions, and using Gaussian and square cosine 
filters for the direct and indirect dimensions, respectively. 
 
2.3.3 Assignment Procedure. Up to 401 13C shifts of microcrystalline fully labeled 
CoMMP-12 could be directly assigned from the 2D PDSD by comparing with the available 
assignment of the diamagnetic ZnMMP-12, by checking the correspondence of the residue 
spin-patterns and using a sequential procedure based on the 3D NCACX and NCOCX 
experiments [as reported in ref 39] 
Up to 318 13C shifts of microcrystalline diluted CoMMP-12 PDSD spectrum were assigned 
for comparison with the fully labeled CoMMP-12 assignment. Differences between the 
diluted and fully labeled CoMMP-12 were assigned following the correspondences in the 
PDSD spin-pattern of each residue, and further confirmed by comparison with the 13C 
solution assignment of CoMMP-12. The weaker peaks due to the protein molecules still 
affected by inter-molecular pcs were recognized and distinguished from the intra-molecular 
pcs peaks by comparison with the fully labeled CoMMP-12 assignment. 
Up to 231 13C shifts of microcrystalline diluted ZnMMP-12 PDSD spectrum were assigned 
for comparison with the fully labeled ZnMMP-12 and following the correspondences in the 
PDSD spin-pattern of each residue; finally the assignment was checked by comparison with 
the inter-molecular pcs obtained as differences between the assignments of the fully labeled 
CoMMP-12 and the diluted CoMMP-12 samples. The weaker peaks due to protein 
molecules not affected by inter-molecular pcs were recognized and distinguished by 
comparison with the diamagnetic assignment in the fully labeled ZnMMP-12. 
Up to 91 cross peak assignment was done using CHHC spectra and 107 cross peak 
assignment was done using different PDSD spectra recorded with different mixing time. 
Both CHHC and PDSD spectra becomes more crowded with increasing mixing time which 
in turn increases the probability of ambiguous assignment. In order to avoid this spectra 
acquired at lower mixing time was used. 
2.3.4 Analysis of the inter-molecular pcs. The pseudocontact shifts ( pcδ ) can be calculated 
in solution from equation 1 (see main text). We assumed equation 1 can be applied to predict 
the solid-state isotropic resonance in rotating paramagnetic solids. The magnetic 
susceptibility tensor was fit through the program PARASOL developed within this work in 
Mathematica language51 on the basis of the available 13C pseudocontact shifts in the diluted 
CoMMP-12 sample (∆χax = (10.3 ± 0.7) 10−32 m3; ∆χrh = (−2.1 ± 0.3) 10−32 m3). These 
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tensor parameters are in perfect agreement with those measured on the solution pcs and 
previously published39  
The calculations to address the position and the tensor orientations of the neighboring metals 
were performed using the PARASOL program, in this case, eq. 2 was used to calculate pcs 
originated by more than one metal. PARASOL is able to use several minimization routines 
(Levenberg-Marquardt algorithm, Gauss-Newton algorithm, conjugate gradients algorithm), 
the best results were obtained with the Levenberg-Marquardt algorithm and using a 
repetitive procedure that starts from different initial guesses. In particular the initial positions 
of the external metals are crucial for the quality of the final minimum. For such reason 
several initial guesses were automatically generated setting up the x, y, and z coordinates of 
the external metals in turn to the values 20, 0 and –20 Å. When the fit was used to fix two 
neighbor proteins, up to 36 (729) different starting conditions were generated, sampling a 
volume of about 216,000 Å3 within a radius of 40-35 Å from the central protein. The final 
minima were chosen among those having the smaller RMSD values 
(
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2)()(
, where the sum run over the m experimental values). 
Running the calculation on the total pcs, around 30% of the initial guesses generated good 
minima. 
The calculations performed on the inter-molecular pcs were conduced in an analogous way, 
but excluding the intra-molecular term from equation 2. 
The arrangement of the external proteins, as shown in Figure 6, was done on the basis of the 
calculated metal position and tensor orientation of the two neighboring proteins. This was 
done aligning the principal axes of the internal tensor of each protein to those one calculated 
for the external metal. An ambiguity results as two tensor orientations with opposite 
orientation of the z axis responds equally well to the experimental pcs. This was solved 
excluding the orientations where the external proteins have a large overlap with the internal 
one. 
 
2.3.5 Calculation of MMP-12 structure with intra-molecular pcs. The MMP-12 structure 
reported in Figure 7 & 10, were calculated using PARAMAGNETICCYANA 52 a derived version 
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of CYANA53  powered to handle paramagnetic restraints. As structural restraints were used: 
318 experimental intra-molecular SS NM pcs (tolerance 0.4 ppm), 155 angle restraints 
obtained from CSI calculation and 152 angle restraints using TALOS on the SSNMR shifts 
of Cα, C’, Cβ nuclei of the fully labeled ZnMMP-12, 21 simulated distance restraints. The 
angle constraints were imposed only on the backbone angle ϕ and ψ, with –150 < ϕ <–90 
and 100 < ψ <180 for β-sheet, and –80 < ϕ <30 and –70 < ψ <–20 for α-helix. Paramagnetic 
tensor parameters ∆χax and ∆χrh were imposed to their typical values (∆χax = 7 10−32 m3; 
∆χrh = –2.4 10−32 m3). Simulated distance restraints were determined from the ZnMMP-12 
X-ray structure40 randomly choosing distances around 6 Å and adding 1.5 Å of tolerance. Up 
to 2000 simulated annealing minimizations were started, collecting a family with the 20 
structures with smaller target function. The reported Figures 7, figure 10 and the structural 
analysis were done using the MOLMOL program.54 
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2.4 Results and Discussion 
2.4.1 Paramagnetic Dilution Strategy. To separate the intra- and inter-molecular pcs 
contributions without previous knowledge of the protein structure, we propose the 
preparation of two samples with two different combinations of protein labeling and dilution 
of the paramagnetic species. In the first scheme (diluted CoMMP-12), 13C,15N-enriched2-
enriched CoMMP-12 (paramagnetic species) is diluted with unlabeled ZnMMP-12 (native 
diamagnetic protein). By crystallizing this mixture in the same conditions previously used 
for the uniformly labeled samples (ZnMMP-12 or CoMMP-12)52,55 we obtained a sample 
where each 13C-labeled paramagnetic protein molecule is – on average –surrounded by 
unlabeled diamagnetic protein molecules. As the 13C-labeled molecules are the sole species 
observable in 13C-13C correlation NMR experiments, we can selectively observe the 
paramagnetic species, which is affected only by the intra-molecular pcs. The cleanest effects 
are of course expected for very high dilutions of the labeled species, which would however 
produce too small signal-to-noise ratios. In practice, a reasonable compromise should be 
found between sensitivity and the increased probability that two paramagnetic protein 
molecules crystallize adjacent to one another, giving rise to peaks further shifted by inter-
molecular effects. Although the best dilution ratio should be determined for each sample on 
the basis of the nature of the sample and of the actual sensitivity (which depends on several 
parameters like amount of sample, probe sensitivity, magnetic field used, etc.) we 
demonstrate in our case that the separation among intra- and inter-molecular pcs is 
affordable using only a factor three dilution, i.e. crystallizing a mixture of 30% 13C, 15N-
enriched CoMMP-12 with 70% unlabeled ZnMMP-12. In such a condition, the intensity of 
the peaks experiencing only intra-molecular pcs, and of those peaks that are still affected by 
both intra- and inter-molecular pcs, can be easily predicted as a function of the dilution ratio. 
Figure 1A shows that using a 30% dilution ratio, the intensity of the peaks affected only by 
intra-molecular pcs (green curve) is sizably higher than those of the peaks affected by both 
contributions (red curve). By using in total 40-45 mg of diluted sample, which is about three 
times more sample than that used in the fully labeled CoMMP-12 sample,3 we can normalize 
the plot in Figure 1 in order to have intensity 3.0 for a dilution ratio of 100% (non-diluted 
sample) and an intensity around 0.7 for a 30% dilution ratio.4 This means that, with this 
                                                 
2 A standard doubly labeled sample was used throughout this work, although 15N pcs were not used. 
3 We used 13-15 mg of fully labeled CoMMP-12 in a 4 mm probe, acquiring spectra at 16.4 T (700 MHz of 
proton Larmor frequency). 
4 The curves reported in Figure 1A-B were calculated considering that 13C nuclei are affected by only one 
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dilution ratio, the intensity of the peaks experiencing purely intra-molecular pcs is around 
70% of that observed in the fully labeled CoMMP-12 sample, allowing us to record spectra 
of similar quality within 2-4 days of acquisition time. Some weak peaks, corresponding to 
the fraction of molecules still experiencing inter-molecular pcs, are observed, but in fact they 
can be easily distinguished and discarded in view of the weak intensity and because they 
have the same shift observed in the fully labeled CoMMP-12 sample. 
The second scheme (figure 1B) here proposed is based on the “inverse dilution”: we 
crystallized a mixture in which 13C,15N-enriched ZnMMP-12 (diamagnetic) is diluted with 
unlabeled CoMMP-12 (paramagnetic). As we can observe only the labeled species, in this 
sample intra-molecular pcs are  
 
 
 
absent and only inter-molecular pcs are observed. Appling here the same calculation 
described above (Figure 1B), we prepared a diluted sample by using 30% 13C,15N-enriched 
ZnMMP-12 with 70% unlabeled CoMMP-12, and we were able to distinguish the peaks 
affected by inter-molecular pcs from those corresponding to the pure diamagnetic species. 
Even in this sample the limited dilution allows one to observe some residual peaks 
corresponding to molecules that are not surrounded by CoMMP-12. These peaks can be 
easily recognized and discarded as they have the same shift of the diamagnetic fully labeled 
                                                                                                                                                      
neighboring protein at time. Under such a condition, the green curves can be calculated by the equation 3x(1-x) 
(where x is the dilution ratio), and the red and blue curves are calculated by  the equation 3x2. 
Fig 1A: The relative intensities expected for the signals
of nuclei experiencing both intra- and inter-molecular
pcs (red line) and only intra-molecular pcs (green line)
in diluted CoMMP-12 sample 
Fig 1B: The relative intensities expected for the signals
of nuclei experiencing no pcs (blue line) and only inter-
molecular pcs (green line) in diluted ZnMMP-12 sample.
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ZnMMP-12.5 
 
2.4.2 Solid-state NMR spectra. The 13C-13C PDSD spectra obtained with the two dilution 
schemes (diluted CoMMP-12 and diluted ZnMMP-12 samples)52,55 were recorded, assigned 
and compared with those of fully-enriched CoMMP-12 and ZnMMP-12 respectively (see 
details in Materials and Methods). Representative portions of these spectra are shown in 
Figure 2, to illustrate the clear separation of the observed pcs into their intra- and inter-
molecular components. It can be appreciated that for some residues, such as Val217, the 
observed pcs are essentially due to the intra-molecular term, so we observed the same shift 
in the fully labeled CoMMP-12 and diluted CoMMP-12 samples (Figure 2A). Likewise, we 
also observe that the shifts of Val217 in the diluted ZnMMP-12 sample, where no intra-
molecular pcs are present, are identical to those of the pure diamagnetic protein (Figure 2C). 
Conversely, for the residues experiencing inter-molecular pcs, such as Thr154, this 
additional interaction is responsible for the differences between the fully labeled CoMMP-12 
and the diluted CoMMP-12 sample (Figure 2B), or between the fully labeled ZnMMP-12 
and the diluted ZnMMP-12 sample (Figure 2D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
5 Paramagnetic spectra are generally less intense than analogous diamagnetic ones. This can be noted for 
example in the diluted ZnMMP-12 sample, where some peaks experiencing sizable inter-molecular pcs are 
even weaker than the residual diamagnetic peaks, even if the latter are much less abundant. 
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Table 1 summarizes the number of meaningful pcs that could be collected from each 
spectrum.  
 
Table 1. Number of assigned pcs for each sample studied. 
 
Sample Number of pcs 
CoMMP-12 401 
Labeled CoMMP-12 diluted  
with unlabeled ZnMMP-12 
318 
Labeled ZnMMP-12 diluted  
with unlabeled CoMMP-12 
231 
 
The complete sets of pcs values are reported as Table 4 Compared to the previous report52, 
the number of assigned pcs in the present fully-enriched CoMMP-12 sample could be nearly 
doubled (401 vs 246) by a careful analysis of the 3D NCOCX and NCACX spectra (see 
details in Materials and Methods). Even the two diluted samples (labeled CoMMP-12 and 
labeled ZnMMP-12) provided a relatively large number of pcs (318 and 231, respectively), 
the smaller number for the inter-molecular pcs arising from the fact that relatively fewer 
protein nuclei are exposed to non-negligible paramagnetic effects from the neighboring 
molecules. 
The intra-molecular pcs measured in the diluted CoMMP-12 sample are in excellent 
agreement with the pcs measured in solution (see Figure 4), as in both cases they depend 
only on the internal metal, and can be calculated from eq. 1 where axχ∆  and rhχ∆  are the 
axial and rhombic components of the magnetic susceptibility tensor anisotropy ( χ ), r is the 
metal-nucleus distance, and θ and ϕ are, respectively, the polar and azimuthal angles 
describing the orientation of the metal-nucleus vector with respect to the principal axes of 
the χ tensor. ( ) 


 −
3
2
3
2 cos2sin
2
313cos
12
1
r
θ∆χ+
r
θ∆χ=δ rhax
pc ϕ
π       eq. 1 
Thus they can be used to determine the five parameters characterizing the magnetic 
susceptibility tensor of the cobalt(II) ion in MMP-12 (two anisotropy parameters ∆χax and 
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∆χrh and the three Euler angles for the orientation of the principal axes of the tensor in the 
molecular frame, see eq. 1) on the basis of the known crystal structure40 PDB code 1RMZ). 
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Fig. 3. 13C pcs observed (blue lines) for (A) a microcrystalline fully labeled CoMMP-12, (B) 
a microcrystalline diluted CoMMP-12, and (C) a microcrystalline diluted ZnMMP-12. The 
green lines are calculated (A) as the sum of contributions from the internal and two nearest 
neighbor cobalt(II) ions, (B) from the internal cobalt(II) ion only, and (C) as the 
contributions from the two nearest neighbor cobalt(II) ions only. 
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Figure 4. Comparison among the experimental liquid-state pcs and intra-molecular SSNMR 
pcs for CoMMP-12. The comparison have been extended over the 246 available solution 
pcs39 
 
The total pcs (sum of the intra- and the inter-molecular pcs), the intra- and the inter-
molecular pcs values, plotted in sequential order, are shown in Figure 3A-C (blue lines), 
together with the calculated values (green lines).6  The latter were obtained using the tensor 
parameters determined above and fixing the position of the metals in the crystal lattice and 
the orientation of the tensors in the neighboring proteins on the basis of the crystallographic 
symmetry group of the X-ray structure. For the total pcs (Figure 3A) the contributions from 
the internal metal and from all the external metals within a radius of 80 Å were summed up, 
while for the intra-molecular pcs (Figure 3B), and the inter-molecular pcs (Figure 3C) only 
the contributions of the internal metal and of the external metals, respectively, were 
considered. The agreement between calculated and experimental values (see also Figure 5) is 
good in all three cases. For the total pcs the RMSD between calculated and experimental 
values is 0.19 ppm, which represents a reasonable limit, as it is of the order of the 
experimental error in the measured pcs (ca. 0.2 ppm). This indicates that the calculated 
values agree with the experimental ones within the error limits, and any further refinement is 
meaningless. 
                                                 
6 For the sake of clarity only the 231 values which are common in the spectra of the three samples (full-labeled 
CoMMP-12, diluted CoMMP-12 and diluted ZnMMP-12) are reported in the plot. 
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Figure 5. Comparison among the calculated and experimental total pcs (A), intra-molecular 
pcs (B) inter-molecular pcs (C). The RMSDs were calculated over 401 pcs for total pcs, 318 
values for intra-molecular pcs , and 231 values for inter-molecular pcs, 
 
In conclusion, using diluted samples two high quality sets of intra- and inter-molecular pcs 
values can be made experimentally available, thus allowing the potential use of the former 
for structural determination (as routinely done in solution), and of the latter for “NMR 
crystallography” purposes. 
Pcs are long-distance restraints: in the present case pseudocontact shifts up to 20-22 Å from 
the metal could be measured. On the other side, the limits posed by shift anisotropy43 or by 
insufficient decoupling56,57 makes the nuclei closer than 9-10 Å from the metal 
unobservable; the perspective of investigating samples at higher MAS frequency suggests 
that this lower limit could be reduced58, but this aspect deserve further investigations. 
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2.4.3 Use of the inter-molecular pcs for structural information on the neighboring 
molecules. In this section we address the question of whether the inter-molecular pcs are of 
good enough quality to actually allow us to obtain meaningful and quantitative information 
on the location and orientation of the neighboring protein molecules, given that the single 
protein structure is known. Since the pcs contributions of each metal are additive, the total 
pcs, observed in the fully labeled CoMMP12-sample can be described by eq. 3 
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where the sum runs over all the n neighboring metal which give a non-negligible 
contribution to pcs, r1 and rn are the distance of the observed nucleus from the internal and 
the nth metal, respectively, θ1, ϕ1, and  θn, ϕn are the polar and azimuthally angles describing 
the position of the observed nucleus with respect to the principal axes of the χ tensor 
relative to the internal and the nth metal, respectively. The paramagnetic tensor parameters 
∆χax and ∆χrh and the orientation of the principal axes of the χ tensor within the protein 
frame are the same for any metal. On these bases, starting from the structure of a single 
protein, one can optimize the position of the internal and external metals and the orientation 
of the principal axes of their χ tensors in order to minimize the RMSD among the 
experimental total pcs and the values calculated through eq. 3. By doing so, the position and 
orientation of the neighboring molecules is also determined. 
While locating a single metal ion in a given structure and determining the parameters of its 
magnetic susceptibility anisotropy tensor requires an eight-parameter fit (i.e. (∆χax, ∆χrh, the 
coordinates x, y and z of the metal and the three Euler’s angles defining the orientation of the 
principal axes of the χ  tensor), increasing the number of metals beyond one requires six 
additional parameters each time (∆χax and ∆χrh being the same for all metals), i.e. 8 
parameters for one metal, 14 for two, 20 for three metals, etc. In addition, while one can 
exploit hundreds of intra-molecular pcs, with both positive and negative signs, to locate the 
internal metal ion, only a few tens of meaningful inter-molecular pcs are available, most of 
which of the same sign, to locate one of the neighboring metals. In fact, only one edge of a 
protein molecule is exposed to the magnetic susceptibility of a neighboring protein. 
In order to fit the position and the magnetic parameters of each metal from the experimental 
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pcs, we developed a computer program, called PARASOL (PARamagnetic Analysis in 
SOLids)7 able to perform a least-square non-linear fit, and to repeat the minimization for 
many automatically generated initial guesses (see Materials and methods). As final 
optimized parameters we chose those giving the minimal RMSD. 
In the best fitting of the intra-molecular pcs (8 parameter fit) the internal metal could be 
placed in a position that is only 0.30 Å away from the crystallographic position, with an 
RMSD of 0.19 ppm. This is a remarkable result, as an indetermination of less than 0.5 Å is 
of the order of the average backbone RMSD for the best NMR structures in solution. 
Once the position and the magnetic parameters of the internal metal are determined from the 
intra-molecular pcs, we fitted the total pcs in order to establish the maximum number of 
external metals that can be safely determined. Thus the total pcs were fitted with eq. 2 using 
first only the internal metal and no external metals, and then adding one, two and three 
external metals. The RMSD thus obtained were 0.87, 0.51, 0.19, and 0.17 ppm, respectively. 
By passing from none to one and from one to two external metals the RMSD decreases 
significantly, while when a third external metal is used the effect is much less important. 
Furthermore, as already pointed out, RMSD below 0.2 ppm are of the order of the 
experimental error in the pcs. Finally, the RMSD obtained in the fit with two or more 
external metals is comparable with the RMSD when the total pcs are calculated from the 
crystallographic positions: therefore, both values reach the limit posed by the pcs 
experimental error, and any further improvement is meaningless; it results that in this case 
only two neighboring protein molecules can be safely placed. 
The best-fit with two neighboring metals yielded the metal position of the neighboring 
proteins at 2.1 and 3.0 Å from the X-ray crystallographic positions for the molecule 1 and 2 
in Figure 6, respectively. 
 On the bases of the fitted orientation of the principal axes of χ  also the orientation of the 
two neighboring protein molecules were determined (see details in Material and Methods). 
In Figure 6 we compare the orientation of the neighbors determined by the SS NMR pcs 
(red) with the X-ray crystallographic positions (blue). It can be seen, even the protein 
arrangements are in reasonably good agreement with the crystallographic positions.  
                                                 
7 Parasol is written by Dr. Moreno Lelli and will be available soon at http://www.postgenomicnmr.net 
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It should be stressed that only the SSNMR paramagnetic restraints have been used in this 
calculation, ignoring any symmetry elements present in the crystalline state. We may 
anticipate that this method applies as such for one-dimensional ordered non-crystalline 
materials such as fibrils. 
 
2.4.4 Applicability of the intra-molecular pcs for structural determination. To 
demonstrate the affordability of the structural determination supported by pcs, we performed 
structural calculations in which a variable number of simulated distance restraints are used 
together with experimental intra-molecular pcs and experimental angle restraints derived 
from Chemical Shift Index (CSI)44. With these calculations we aimed at showing how using 
a large number of easily determinable structural restraints (such as 318 experimental intra-
molecular pcs and 155 angle restraints obtained from CSI analysis) can be used to strongly 
reduce the number of distance restraints needed to achieve a structure. In Figure 7 we show 
that a very small number of randomly chosen simulated distance restraints (21 distance 
restraints, less than 1 distance restraint over 7 AA!) reported in table 2, together with the 
above indicated experimental restrains and using standard values for the paramagnetic tensor 
parameters ∆χax and ∆χrh 59(eq. 1) are enough to define the overall protein fold and to define 
some secondary structural elements with a total RMSD of 4.45 Å (3.12 Å on the secondary 
structure elements) (Figure 7C ). The impact of the pcs restraints is apparent when the same 
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calculation is performed without pcs, and only a fairly unclear structure with RMSD of 9.64 
Å, with 7.30 Å on the secondary structure elements is obtained (Figure 7B). Such 
calculations show that some distance restraints are always needed, otherwise pcs alone 
hardly converge to a correct folding.35,60 
As pcs and CSI restraints are easily obtained from the NMR assignment, it appears that pcs 
may be really precious for structural determination in SSNMR. 
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Table 2. Table of distance restraints between the nuclei 1 and 2. The reported distances have 
been already added with 1.5 Å of tolerance. 
 
NUCLEUS 1 NUCLEUS 2 
Residue N° Residue type Atom type Residue N° Residue type Atom type 
Distance (1.5 
Å added) 
141 TRP Hα 250 LEU Hδ12 6.28 
213 PHE Hβ2 245 ILE Hγ21 6.84 
114 ILE Hβ 224 LEU Hδ21 6.64 
118 ILE Hβ 151 LYS HE2 6.59 
125 MET Hβ2 212 LEU Hδ22 6.59 
129 ASP- Hβ2 205 THR Hγ21 6.33 
130 VAL Hγ12 161 VAL Hγ11 6.9 
134 ILE Hα 216 ALA Hβ2 6.18 
136 LYS Hζ1 246 ASN Hα 6.38 
137 ALA Hα 220 ILE Hδ12 6.33 
140 VAL Hγ13 249 ARG+ Hα 6.57 
144 VAL Hβ 255 ILE Hα 6.03 
147 LEU Hδ11 258 ILE Hδ12 6.98 
159 ILE Hα 223 SER Hβ3 6.7 
161 VAL Hγ21 220 ILE Hδ11 6.55 
164 ALA Hα 199 GLU- Hβ3 6.1 
170 ASP- Hα 191 ILE Hδ11 6.33 
181 LEU Hβ2 215 THR Hγ1 6.69 
182 ALA Hα 219 GLU- Hγ3 6.65 
194 ASP- Hα 223 SER Hγ 6.35 
214 LEU Hβ3 243 VAL Hγ22 6.61 
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Fig. 7. Families of 10 simulated structures (B) without paramagnetic restraints, (C) with 
paramagnetic restraints 
 
2.4.5 Structure elucidation of ZnMMP12 
In the strategy proposed in this work, we introduce the use of pcs as structural restraints for 
the structural determination of protein in the solid phase. With respect to the NMR protein 
structural determination in solution, the use of pcs in the SSNMR structural determination 
may be even more important: as the number of distance restraints usually collected for the 
protein structure determination is much smaller than those routinely collected in solution, the 
structural refinement expected by the use of pcs may be even more significant. 
The recent development of the SSNMR MAS technique provides nowadays several 
recoupling sequences61,62 able to determine, even with comparably high precision, 
internuclear distances. Unfortunately, the most of these sequences require selective pulses or 
specific labeling schemes,9 while broadband recoupling sequences are more profitable to 
collect the large number of distance restraints needed to determine the protein structure. 
One of the most successful strategies is using Proton Driven Spin Diffusion (PDSD) 
sequence on selectively labeled protein samples to collect large numbers of distance 
restraints9 However, using the same sequence for uniformly labeled samples would result in 
too overcrowded spectra leading to intricacy of resonance assignments. Alike PDSD, the 
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CHHC sequence provides distance restraints even using uniformly labeled proteins63. In this 
sequence, a cross-polarization (CP) transfer block is used to force the magnetization transfer 
from 13C to covalently bound 1H nuclei letting the 1H-1H spin diffusion during the mixing 
time; finally the magnetization is transferred back on 13C for detection, which provides a 
much higher resolution than direct 1H detection. The CHHC spectrum appears as a 2D 13C-
13C map, the aliphatic region of which is more or less analogous to the one observed in 13C-
13C PDSD, but with respect to this it encodes 1H-1H contacts. The forced transfer on 1H 
nuclei before the spin-diffusion step reduces the effects of the dipolar truncation which 
should be expected in the PDSD spectrum in view of the uniform labeling. The CHHC47,63 
sequence was used to determine the structure of a small protein (38 residues)19 providing 
distance restraints in the range of 5-6 Å. 
In this work we want to demonstrate how the use of PCS as complementary distance 
restraints allows one to determine at least a low-resolution structure but on a relatively large 
protein (159 AA) and using only uniformly labeled samples. The strategy we adopted is to 
collect together pcs and backbone dihedral angle restraints, which can be easily determined 
directly from the assignment of the paramagnetic and the diamagnetic protein and by using 
the CSI or TALOS programs, with distance restraints determined through CHHC and PDSD 
experiments on the uniformly labeled sample. 
As pcs and TALOS dihedral angles are easily determined, they can be collected in large 
amount (318 and 152, respectively) allowing us to reduce to minimum the distance restraints 
needed. These were obtained primarily by using the CHHC spectrum (91 distance restraints) 
acquired at 150 µs of mixing time (Figure 8A & 8B). These inter-residual distance 
correlation was found to be all within 6 Å, checking on the known X-Ray structure. On this 
basis we intend to use any correlation assigned in the CHHC spectrum as a distance restraint 
upper limited to 6 Å. We believe this limit is large enough to be generally considered 
independent on the nature of the protein. This allowed us to avoid the consideration of all X-
ray information and to collect distance restraints only on the basis of the experimental 
spectra. 
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In addition to CHHC we also acquired PDSD spectra at different mixing times (from 15ms, 
60ms, 100ms and 200 ms) in order to provide additional distance restraints. Comparing the 
CHHC spectra at 150 µs with the PDSD spectra at 60-200ms, it is apparent how the PDSD 
spectrum is more intense but even more crowded than the CHHC spectra. The assignment of 
PDSD spectra was difficult owing to overlap and ambiguity. However, 107 cross peak were 
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assigned primarily following the most resolved peaks primarily. Most of these assignments 
were found to be sequential assignments. They included 19 sequentially long-range and 9 
sequentially medium range correlations. In uniformly labeled sample, the PDSD mechanism 
rapidly transfers magnetization intra-residue along the C-C bonds: this allowed us to observe 
all the intra-residue correlations already at 15 ms. On the other hand, the effect of the dipolar 
truncation and the relayed magnetization transfer strongly reduces the intensity of the direct 
long-range correlation in the PDSD. In such a condition the PDSD cross-peak cannot be 
used for direct measurement of the inter-nuclear distance but they must be categorized with a 
generic upper limit that takes into account the relayed spin diffusion mechanisms. Thus, we 
observed that by using a general upper limit of 9 Å for any assigned cross-peaks in the 60-
200 ms PDSD spectra we collect a series of “loose” distance restraints but that are still useful 
for the structural determination. These primarily achieved distance restraints along with 
torsion angle restraints and intra-molecular pcs restraints were used to calculate structure 
using CYANA. A low resolution structure with a RMSD of 3.2Å (2.33Å with respect to X-
ray secondary structure (Figure 10B) was determined from this calculation. We demonstrate 
that the use of pcs at this point has intense effect since the same calculation without the 
presence of the pcs constraints results in fairly unresolved structure with a RMSD (figure 
10A). We believe that this low resolution structure can be refined by further addition of more 
restraints). However, overcrowded PDSD spectra (Figure 9) acquired with increasing mixing 
time restricted the further assignment of more sequentially long-range correlation. In order to 
avoid ambiguity we can take this low resolution structure as a primary model structure while 
adding new restraints through unambiguous resonance assignments. (This further 
improvement of the structure is presently in progress)  
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Table 3 summarizes the total no of constraints derived experimentally including distance 
restraints, torsion angle restraints and intra-molecular pcs. 
 Number Distance 
Total  number of distance restraints 271 - 
Total number of distance restraints from CHHC spectra 
analysis 
 
91 6Å 
Number of sequential distance restraints from CHHC 
spectra analysis (|i-j|) = 1 
29 6Å 
Number of Medium range distance restraints from CHHC 
spectra analysis [1 < (|i-j|) ≤ 4 
 
26 6Å 
Number of long range distance restraints from CHHC 
spectra analysis (|i-j|) > 4 
 
36 6Å 
Total number of distance restraints from PDSD spectra 
analysis 
 
107 9Å 
Number of sequential distance restraints from PDSD 
spectra analysis (|i-j|) = 1 
 
70 9Å 
Number of Medium range distance restraints from PDSD 
spectra analysis [1 < (|i-j|) ≤ 4 
 
18 9Å 
Number of long range distance restraints from PDSD 
spectra analysis (|i-j|) > 4 
 
19 9Å 
Total number of TALOS calculated torsion angles 152  
Total number of intra-molecular pcs used 318  
RMSD with respect to X-ray (PDB 1RMZ) secondary 
structural element, using 198 distance restraints + 152 
TALOS calculated torsion angles + 318 intra-molecular 
pcs restraints. 
 
2.33 Å  
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Figure 10: Families of 10 simulated structures (A) without paramagnetic restraints, (B) 
with paramagnetic restraints 
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Table 4: Complete set of pcs values Errors in the pcs values are estimated of the order of ±0.2 Å 
Data collected at 16.4 T (which corresponds to a 1H Larmor Frequency of 700 MHz) the probe 
temperature was 270 K that corresponds to an estimated sample temperature   280 K.  
Total PCS PCS internal PCS external 
Residues a.a Atom Calc 
(ppm) 
Obs 
(ppm) 
Calc 
(ppm) 
Obs 
(ppm) 
Calc 
(ppm) 
Obs 
(ppm) 
114 ILE C' 0.56 0.66     
114 ILE Cα 0.58 0.45 0.42 0.12 0.16 0.15 
114 ILE Cβ 0.69 0.58 0.55 0.27 0.15 0.30 
114 ILE Cγ1 0.69 0.61 0.56 0.22 0.13 0.23 
114 ILE Cγ2 0.72 0.64 0.58 0.23 0.15 0.23 
114 ILE Cδ1 0.83 0.64 0.72 0.27 0.11 0.25 
115 THR C' 0.51 0.57 0.28 0.40 0.23 0.30 
115 THR Cα 0.49 0.50 0.27 0.26 0.22 0.15 
115 THR Cβ 0.44 0.48 0.20 0.26 0.24 0.19 
115 THR Cγ2 0.40 0.46 0.19 0.23 0.21 0.13 
116 TYR C' 0.42 0.51     
116 TYR Cα 0.47 0.60 0.21 0.24   
116 TYR Cβ 0.51 0.76 0.29 0.57   
117 ARG C' 0.26 0.52 -0.09 0.09   
117 ARG Cα 0.36 0.51 -0.02 0.28 0.38 0.25 
117 ARG Cβ 0.44 0.68 -0.04 -0.05 0.49 0.37 
117 ARG Cγ 0.49 0.62 -0.07 0.02   
117 ARG Cδ 0.70 0.92 -0.07 -0.09   
118 ILE C' 0.12 0.19     
118 ILE Cα 0.11 0.18 -0.18 -0.08 0.30 0.32 
118 ILE Cβ 0.08 0.26 -0.17 0.12 0.25 0.24 
118 ILE Cγ1 0.10 0.21 -0.12 0.03 0.22 0.10 
118 ILE Cγ2 -0.03 0.14 -0.25 -0.05 0.22 0.17 
118 ILE Cδ1 0.09 0.15 -0.09 0.04 0.19 0.12 
119 ASN C' 0.04 0.16     
119 ASN Cα 0.09 0.16     
119 ASN Cβ 0.01 0.10     
119 ASN Cγ 0.05 0.29     
120 ASN C' -0.16 0.05 -0.36 -0.30 0.20 0.30 
120 ASN Cα -0.09 -0.04 -0.33 -0.24 0.24 0.14 
120 ASN Cβ -0.10 -0.04 -0.35 -0.26 0.25 0.20 
120 ASN Cγ -0.18 -0.01 -0.44 -0.34 0.26 0.17 
121 TYR Cα -0.19 -0.33     
122 THR C' -0.25 -0.06 -0.34 -0.34 0.09 -0.01 
122 THR Cα -0.31 -0.20 -0.42 -0.34 0.11 -0.15 
122 THR Cβ -0.41 -0.31 -0.50 -0.44 0.09 -0.10 
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122 THR Cγ2 -0.40 -0.31 -0.48 -0.44 0.08 -0.13 
123 PRO Cα -0.19 -0.18 -0.26 -0.20 0.07 0.00 
123 PRO Cβ -0.16 -0.08 -0.24 -0.14 0.08 0.05 
123 PRO Cγ -0.18 -0.09 -0.28 -0.06 0.10 0.08 
123 PRO Cδ -0.22 -0.17 -0.32 -0.29 0.11 -0.02 
124 ASP Cα -0.27 -0.11 -0.29 -0.22 0.02 0.08 
124 ASP Cβ -0.34 -0.23 -0.35 -0.13 0.01 -0.02 
124 ASP Cγ -0.36 -0.27 -0.38 -0.40 0.01 -0.10 
125 MET C' -0.14 -0.22     
125 MET Cα -0.19 -0.16 -0.24 -0.06 0.06 0.02 
125 MET Cβ -0.21 -0.17 -0.28 -0.15 0.06 -0.09 
125 MET Cγ -0.27 -0.22 -0.32 -0.18 0.04 0.02 
126 ASN Cα -0.06 -0.05 -0.15 -0.14 0.09 -0.06 
126 ASN Cβ -0.01 0.18 -0.12 0.13 0.11 0.12 
127 ARG C' -0.02 0.11     
127 ARG Cα -0.06 0.01     
127 ARG Cβ -0.06 -0.05 -0.13 -0.20 0.07 -0.04 
127 ARG Cγ -0.05 -0.02 -0.12 -0.05 0.08 -0.03 
128 GLU Cα 0.04 0.27 -0.07 0.19 0.11 0.13 
128 GLU Cβ 0.06 0.18 -0.06 -0.02 0.11 -0.01 
128 GLU Cγ 0.07 0.29 -0.04 0.03 0.10 -0.03 
129 ASP C' -0.02 0.14 -0.13 0.03 0.11 0.05 
129 ASP Cα 0.01 0.17 -0.11 -0.08 0.12 0.02 
129 ASP Cβ -0.01 0.11 -0.13 -0.16 0.12 -0.01 
130 VAL C' 0.00 0.02 -0.12 -0.14 0.12 -0.14 
130 VAL Cα -0.08 -0.07 -0.19 -0.10 0.11 -0.03 
130 VAL Cβ -0.12 -0.09 -0.23 -0.16 0.11 -0.04 
130 VAL Cγ1 -0.15 -0.10 -0.28 -0.16 0.12 -0.03 
130 VAL Cγ2 -0.18 -0.10 -0.28 -0.16 0.10 -0.03 
132 TYR C' 0.20 0.29 0.08 0.20 0.12 0.03 
132 TYR Cα 0.18 0.20 0.05 0.07 0.13 0.00 
132 TYR Cβ 0.16 0.18 0.02 -0.03 0.13 0.00 
133 ALA C' 0.24 0.19 0.13 0.07 0.11 -0.05 
133 ALA Cα 0.14 0.27 0.03 0.12 0.10 0.05 
133 ALA Cβ 0.01 0.16 -0.09 0.05 0.09 0.16 
134 ILE C' 0.45 0.34 0.33 0.08 0.13 0.03 
134 ILE Cα 0.32 0.30 0.20 0.11 0.12 0.05 
134 ILE Cβ 0.23 0.24 0.09 0.14 0.14 0.10 
134 ILE Cγ1 0.04 0.06 -0.09 -0.08 0.13 0.00 
134 ILE Cγ2 0.33 0.33 0.18 0.22 0.15 0.13 
134 ILE Cδ1 -0.03 -0.04 -0.14 -0.20 0.12 -0.04 
135 ARG C' 0.53 0.46 0.40 0.23 0.13 0.09 
135 ARG Cα 0.45 0.35 0.31 0.22 0.14 0.19 
135 ARG Cβ 0.38 0.33 0.23 0.15 0.14 0.03 
135 ARG Cγ 0.41 0.30 0.25 0.13 0.15 -0.01 
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135 ARG Cδ 0.35 0.26 0.20 0.16 0.15 0.07 
136 LYS C' 0.68 0.51 0.58 0.46 0.10 0.21 
136 LYS Cα 0.52 0.34 0.41 0.26 0.11 0.16 
136 LYS Cβ 0.42 0.52 0.31 0.25 0.11 0.09 
136 LYS Cγ 0.35 0.21 0.23 0.10 0.12 0.10 
137 ALA C' 1.23 1.22 1.14 1.01 0.10 0.10 
137 ALA Cα 1.04 1.12 0.94 0.84 0.09 0.18 
137 ALA Cβ 1.06 1.01 0.97 0.99 0.09 -0.01 
138 PHE C' 1.05 1.10 0.93 0.97 0.12 -0.06 
138 PHE Cα 1.13 1.16 1.02 1.17 0.12 -0.04 
138 PHE Cβ 0.95 0.97 0.81 0.74 0.14 0.15 
139 GLN Cα 0.78 0.88 0.66 0.65 0.12 0.18 
139 GLN Cβ 0.65 0.71 0.53 0.54 0.12 0.13 
139 GLN Cγ 0.57 0.61 0.44 0.43 0.12 0.12 
140 VAL C' 1.14 1.05 1.08 1.15 0.06 0.12 
140 VAL Cα 1.02 1.02 0.95 0.94 0.07 0.10 
140 VAL Cβ 1.17 1.18 1.11 1.09 0.07 0.09 
140 VAL Cγ1 1.29 1.11 1.23 1.58 0.06 0.09 
140 VAL Cγ2 0.92 1.21 0.86 1.40 0.07 0.08 
141 TRP C' 1.15 1.25 1.09 1.26   
141 TRP Cα 1.44 2.10 1.38 1.74 0.06 0.15 
141 TRP Cβ 1.83 2.17 1.76 1.95 0.07 0.10 
142 SER C' 0.74 0.82 0.66 0.87 0.09 0.02 
142 SER Cα 0.86 0.89 0.76 0.87 0.10 0.09 
142 SER Cβ 0.79 0.85 0.66 0.74 0.13 -0.02 
144 VAL C' 0.59 0.79     
144 VAL Cα 0.57 0.68 0.61 0.71 -0.05 -0.25 
144 VAL Cβ 0.61 0.62 0.67 0.56 -0.06 -0.19 
144 VAL Cγ1 0.51 0.61 0.60 0.53 -0.08 -0.15 
144 VAL Cγ2 0.87 0.89 0.89 0.99 -0.02 -0.11 
145 THR C' 0.59 0.69 0.53 0.66 0.05 0.02 
145 THR Cα 0.64 0.64 0.62 0.60 0.02 -0.06 
145 THR Cβ 0.79 0.88 0.76 0.78 0.03 -0.01 
145 THR Cγ2 0.93 1.04 0.92 1.18 0.02 0.10 
146 PRO Cα 0.54 0.57 0.43 0.54 0.10 0.02 
146 PRO Cβ 0.48 0.57 0.48 0.42 0.38 0.02 
146 PRO Cγ 0.47 0.55 0.47 0.39 0.41 0.01 
146 PRO Cδ 0.53 0.60 0.53 0.48 0.49 -0.02 
147 LEU Cβ 0.85 1.17     
147 LEU Cγ 0.89 1.64     
147 LEU Cδ1 1.11 1.22     
148 LYS C' 0.65 0.70 0.46 0.55 0.19 0.12 
148 LYS Cα 0.65 0.70 0.45 0.48 0.20 0.22 
148 LYS Cβ 0.60 0.67 0.36 0.34 0.24 0.22 
148 LYS Cγ 0.58 0.57 0.32 0.33 0.26 0.19 
 92
148 LYS Cδ 0.60 0.54 0.30 0.27 0.30 0.16 
149 PHE C' 0.57 0.57     
149 PHE Cα 0.65 0.61     
149 PHE Cβ 0.73 0.64     
150 SER C' 0.44 0.48 0.23 0.20 0.21 0.13 
150 SER Cα 0.46 0.37 0.26 0.21 0.20 0.13 
150 SER Cβ 0.42 0.38 0.22 0.15 0.19 0.10 
151 LYS Cα 0.38 0.40 0.16 0.11 0.22 0.21 
151 LYS Cβ 0.35 0.40 0.15 0.49 0.20 0.28 
151 LYS Cγ 0.32 0.41 0.10 0.33 0.22 0.38 
151 LYS Cδ 0.28 0.37 0.09 0.21 0.19 0.25 
151 LYS Cε 0.24 0.48 0.04 0.18 0.20 0.13 
152 ILE C' 0.47 0.43 0.03 0.03 0.44 0.33 
152 ILE Cα 0.42 0.66 0.06 0.04 0.36 0.27 
152 ILE Cβ 0.48 0.79 0.06 -0.15 0.42 0.45 
152 ILE Cγ1 0.54 0.91 0.05 -0.08   
152 ILE Cγ2 0.40 0.80 0.09 -0.03   
152 ILE Cδ1 0.66 0.82 0.03 -0.15   
154 THR C’ 1.60 1.79 -0.02 0.08 1.62 1.80 
154 THR Cα 1.61 1.96 -0.03 0.01 1.64 1.90 
154 THR Cβ 2.31 2.76 -0.03 -0.06 2.34 2.72 
155 GLY C' 1.12 1.05     
155 GLY Cα 1.61 1.64     
156 MET Cα 0.69 0.87 -0.01 0.12 0.70 0.91 
156 MET Cβ 0.60 0.86 0.00 -0.14   
156 MET Cγ 0.66 0.78 -0.02 -0.03 0.68 0.60 
157 ALA C' 0.39 0.60 0.06 0.14 0.33 0.36 
157 ALA Cα 0.45 0.58 0.05 0.15 0.40 0.46 
157 ALA Cβ 0.45 0.60 0.05 0.06 0.41 0.38 
158 ASP Cα 0.38 0.59 0.16 0.29 0.22 0.33 
158 ASP Cβ 0.45 0.34 0.26 -0.06 0.19 0.10 
158 ASP Cγ 0.41 0.24 0.24 -0.13   
159 ILE C' 0.28 0.42 0.03 0.10 0.25 0.20 
159 ILE Cα 0.39 0.49 0.18 0.11 0.21 0.17 
159 ILE Cβ 0.58 0.72 0.40 0.50 0.18 0.20 
159 ILE Cγ1 0.76 0.76 0.61 0.48 0.15 0.13 
159 ILE Cγ2 0.56 0.54 0.40 0.34 0.17 0.20 
159 ILE Cδ1 1.05 1.21 0.92 0.38   
160 LEU Cα 0.06 0.17 -0.23 -0.05 0.29 0.22 
160 LEU Cβ 0.03 0.15 -0.30 -0.11 0.33 0.25 
160 LEU Cγ1 0.06 0.31 -0.32 -0.06   
160 LEU Cδ1 0.22 0.22 -0.22 -0.26 0.44 0.29 
160 LEU Cδ2 0.05 0.34 -0.35 -0.15   
161 VAL C' -0.38 -0.30     
161 VAL Cα -0.29 -0.21 -0.52 -0.48   
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161 VAL Cβ -0.17 -0.14 -0.38 -0.10   
161 VAL Cγ1 -0.36 -0.29 -0.53 -0.40   
161 VAL Cγ2 0.01 0.00 -0.17 -0.19   
162 VAL C' -0.79 -0.61     
162 VAL Cα -0.60 -0.60 -0.84 -0.78   
162 VAL Cβ -0.62 -0.47 -0.88 -0.61   
162 VAL Cγ1 -0.52 -0.41 -0.81 -0.68   
162 VAL Cγ2 -0.42 -0.36 -0.71 -0.49   
163 PHE Cα -0.70 -0.71     
163 PHE Cβ -0.59 -0.81     
164 ALA C' -0.48 -0.46 -0.72 -0.77   
164 ALA Cα -0.46 -0.52 -0.73 -0.70   
164 ALA Cβ -0.43 -0.57 -0.74 -0.87   
165 ARG C' -0.13 -0.12     
165 ARG Cα -0.24 -0.14     
165 ARG Cβ -0.15 0.02     
165 ARG Cγ 0.00 0.05     
165 ARG Cδ 0.04 0.23     
166 GLY C' -0.01 -0.10     
166 GLY Cα 0.01 0.10     
167 ALA C' 0.10 0.19 -0.33 -0.39   
167 ALA Cα 0.10 0.15 -0.26 -0.09   
167 ALA Cβ 0.22 0.25 -0.18 -0.03   
169 GLY C' -0.05 0.06 -0.43 -0.06   
169 GLY Cα 0.07 0.01 -0.39 0.23   
171 ASP Cβ -0.14 -0.34     
171 ASP Cγ -0.08 -0.02     
172 HIS Cα -0.33 -0.28     
172 HIS Cβ -0.66 -0.50     
173 ALA C' -0.07 -0.23     
173 ALA Cα -0.07 -0.19 -0.21 -0.30   
173 ALA Cβ 0.09 0.19 -0.09 0.04 0.18 0.11 
175 ASP C' 0.22 0.32     
175 ASP Cα 0.28 0.39     
175 ASP Cβ 0.50 0.36     
175 ASP Cγ 0.60 0.72     
176 GLY C' 0.01 0.16     
176 GLY Cα 0.06 0.14     
177 LYS C' 0.02 0.13     
177 LYS Cα -0.07 0.11 0.01 0.14   
177 LYS Cβ -0.09 0.04 -0.01 -0.04 -0.08 -0.12 
177 LYS Cγ -0.17 0.07 -0.05 0.02 -0.11 0.03 
177 LYS Cδ -0.17 -0.01 -0.05 -0.01 -0.12 -0.06 
178 GLY C' 0.38 0.33     
178 GLY Cα 0.13 -0.02     
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179 GLY C' 1.53 0.56     
179 GLY Cα 1.15 0.66     
186 GLY C' 0.25 0.25     
186 GLY Cα 0.24 0.21     
187 PRO C' 0.18 0.38     
187 PRO Cα 0.40 0.73 0.39 0.66   
187 PRO Cβ 0.52 0.56 0.50 0.50 0.01 0.05 
187 PRO Cγ 0.79 1.11 0.78 0.38   
187 PRO Cδ 0.75 1.07 0.76 1.02 -0.01 0.08 
188 GLY C' 0.06 0.37 0.00 0.19   
188 GLY Cα 0.06 0.26 0.03 0.22   
189 SER C' 0.00 0.13     
189 SER Cα 0.04 0.14 -0.05 -0.11 0.09 -0.05 
189 SER Cβ 0.02 0.19 -0.05 -0.05 0.07 0.01 
190 GLY C' -0.04 -0.10 -0.23 -0.66 0.19 0.23 
190 GLY Cα 0.01 0.14 -0.17 -0.23 0.18 0.19 
191 ILE Cα -0.25 -0.35 -0.42 -0.56   
191 ILE Cβ -0.35 -0.32 -0.52 -0.40   
191 ILE Cγ1 -0.52 -0.36 -0.70 -0.47   
191 ILE Cγ2 -0.40 -0.28 -0.52 -0.38   
191 ILE Cδ1 -0.54 -0.53 -0.73 -0.58   
192 GLY C' -0.01 -0.19     
192 GLY Cα -0.14 -0.21     
193 GLY C' 0.13 0.33 0.02 0.42 0.11 0.04 
193 GLY Cα 0.30 0.45 0.21 0.18 0.10 0.13 
194 ASP C' -0.85 -0.66 -0.98 -1.13   
194 ASP Cα -0.42 -0.70 -0.57 -1.05   
194 ASP Cβ -0.49 -0.42 -0.68 -0.46   
194 ASP Cγ -0.22 -0.03 -0.44 -0.31   
195 ALA C' -1.86 -1.65 -1.99 -2.03   
195 ALA Cα -1.54 -1.25 -1.65 -1.72 0.11 0.15 
195 ALA Cβ -0.89 -0.84 -1.00 -0.94 0.10 0.11 
196 HIS C' -3.03 -2.93 -3.12 -3.17   
196 HIS Cα -2.43 -2.58 -2.55 -2.62   
196 HIS Cβ -2.28 -2.43 -2.40 -2.48   
197 PHE C' -1.80 -1.81 -1.88 -1.98 0.08 0.11 
197 PHE Cα -2.39 -2.18 -2.46 -2.42 0.07 0.02 
197 PHE Cβ -1.96 -1.84 -2.04 -2.22   
201 GLU Cα -0.58 -0.53 -0.52 -0.26   
201 GLU Cβ -0.80 -0.37 -0.73 -0.32   
201 GLU Cγ -0.90 -0.25 -0.83 -0.45   
201 GLU Cδ -0.57 -0.35 -0.47 -0.63   
202 PHE C' -0.56 -0.38     
202 PHE Cα -0.49 -0.52 -0.41 -0.92   
202 PHE Cβ -0.43 -0.39 -0.32 -0.56   
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203 TRP C' -0.50 -0.32     
203 TRP Cα -0.61 -0.58 -0.58 -0.59 -0.03 0.13 
203 TRP Cβ -0.65 -0.79 -0.66 -0.95 0.01 0.06 
204 THR C' -0.33 -0.23     
204 THR Cα -0.39 -0.24 -0.36 -0.28 -0.03 -0.11 
204 THR Cβ -0.41 -0.39 -0.33 -0.59 -0.08 -0.02 
204 THR Cγ2 -0.43 -0.26 -0.31 0.03   
205 THR Cα -0.16 0.18 -0.21 0.13   
205 THR Cβ -0.07 0.15 -0.16 0.07   
205 THR Cγ2 -0.05 0.16 -0.16 0.11   
206 HIS Cα -0.23 -1.06     
207 SER Cα -0.45 -0.32 -0.23 -0.23 -0.21 -0.26 
207 SER Cβ -0.45 -0.28 -0.20 -0.03 -0.25 -0.22 
209 GLY C' -0.61 -0.55     
209 GLY Cα -0.55 -0.46     
210 THR C' -0.83 -0.93 -0.73 -0.94 -0.09 -0.25 
210 THR Cα -0.83 -0.74 -0.70 -0.67 -0.13 -0.18 
210 THR Cβ -1.00 -0.96 -0.88 -0.89 -0.12 -0.10 
210 THR Cγ2 -1.35 -1.27 -1.24 -1.40 -0.12 -0.17 
211 ASN Cβ -0.55 -0.34     
211 ASN Cγ -0.38 -0.23     
212 LEU C' -0.52 -0.40     
212 LEU Cα -0.71 -0.68 -0.73 -0.74 0.02 0.07 
212 LEU Cβ -0.56 -0.39 -0.60 -0.58 0.04 0.08 
212 LEU Cγ -0.54 -0.35 -0.60 -0.35   
214 LEU Cα -0.10 -0.20 -0.13 -0.23 0.03 0.10 
214 LEU Cβ -0.40 -0.42 -0.42 -0.40 0.02 0.00 
214 LEU Cδ1 -0.40 -0.11 -0.40 -0.10   
215 THR Cα -1.96 -1.22 -1.95 -1.42 0.00 -0.05 
215 THR Cβ -2.69 -2.53 -2.66 -2.67 -0.02 -0.04 
215 THR Cγ2 -4.67 -4.44 -4.63 -4.86 -0.04 -0.07 
216 ALA C' 1.94 1.76 1.88 1.80 0.06 0.12 
216 ALA Cα 0.44 0.24 0.38 -0.05 0.05 0.05 
216 ALA Cβ 0.27 0.21 0.20 0.00 0.07 0.11 
217 VAL C' 5.61 5.47 5.55 5.59 0.06 -0.11 
217 VAL Cα 3.07 2.80 3.00 3.00 0.07 0.09 
217 VAL Cβ 2.29 1.96 2.22 1.98 0.07 0.04 
217 VAL Cγ1 2.71 2.43 2.63 2.63 0.08 -0.04 
217 VAL Cγ2 1.45 1.39 1.38 1.45 0.07 0.05 
220 ILE Cα 4.86 4.90 4.79 4.96 0.06 0.08 
220 ILE Cβ 3.31 3.20 3.23 3.19 0.08 0.06 
220 ILE Cγ1 2.15 2.15 2.05 2.13 0.09 -0.10 
220 ILE Cγ2 2.72 2.79     
220 ILE Cδ1 1.58 1.66 1.47 1.66 0.10 0.13 
224 LEU Cα 2.36 2.63     
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224 LEU Cβ 2.56 2.72 2.52 2.80   
224 LEU Cγ 2.40 2.48     
224 LEU Cδ1 2.39 1.97 2.32 1.80   
225 GLY C' 1.88 2.22 1.92 2.17   
225 GLY Cα 1.73 1.93 1.76 1.76   
230 SER C' 1.05 1.39 -1.74 -1.83   
230 SER Cα 0.00 0.28 -2.14 -2.43 2.13 2.35 
230 SER Cβ 0.75 0.96 -1.63 -1.76 2.38 2.53 
231 ASP C' 0.47 0.81     
231 ASP Cα 0.76 1.22 -1.35 -1.22 2.10 2.45 
231 ASP Cβ 0.37 0.70 -1.12 -1.13 1.49 1.78 
231 ASP Cγ 0.44 0.86 -0.85 -0.56 1.29 1.65 
232 PRO C' 0.19 0.46     
232 PRO Cα 0.68 1.00 -1.29 -1.24 1.97 2.07 
232 PRO Cβ 1.47 1.83 -0.97 -1.09 2.44 2.70 
232 PRO Cγ 2.27 2.97     
232 PRO Cδ 2.27 2.68 -0.97 -0.95   
233 LYS C' -0.06 0.26     
233 LYS Cα 0.14 0.38 -0.74 -0.75   
233 LYS Cβ 0.31 0.51 -0.54 -0.90   
233 LYS Cγ 0.46 0.58 -0.49 -0.86   
233 LYS Cδ 0.33 0.56 -0.39 -0.51   
234 ALA C' -0.64 -0.59 -1.10 -1.15 0.46 0.33 
234 ALA Cα -0.36 -0.10 -0.94 -0.52 0.59 0.72 
234 ALA Cβ -0.62 -0.27 -1.26 -1.22 0.64 0.82 
242 TYR Cα -0.53 -0.99 -0.43 -1.08 -0.10 -0.02 
242 TYR Cβ -0.51 -0.56 -0.35 -0.86 -0.16 -0.25 
243 VAL C' -0.20 -0.14 -0.19 -0.32 -0.01 -0.07 
243 VAL Cα -0.26 -0.08 -0.25 -0.19 -0.01 -0.05 
243 VAL Cγ1 -0.27 -0.12 -0.35 -0.23 0.09 -0.01 
243 VAL Cγ2 -0.16 -0.06 -0.22 -0.18 0.07 -0.04 
244 ASP C' -0.05 -0.10     
244 ASP Cβ -0.09 0.15     
245 ILE C' 0.09 -0.08 0.04 -0.23 0.05 0.08 
245 ILE Cα 0.03 0.05 -0.01 0.04 0.04 0.06 
245 ILE Cβ 0.03 -0.23 -0.03 -0.10 0.05 -0.01 
245 ILE Cγ1 0.03 -0.09 -0.04 0.24   
245 ILE Cγ2 -0.06 -0.38 -0.09 -0.45   
246 ASN Cα 0.10 0.27     
246 ASN Cβ 0.09 0.32     
247 THR Cα 0.05 -0.13 0.04 -0.24 0.01 -0.05 
247 THR Cβ 0.00 -0.05 0.00 -0.03 -0.01 -0.04 
247 THR Cγ2 -0.02 0.03 -0.03 0.09 0.01 -0.06 
248 PHE Cα 0.16 0.27 0.11 0.03 0.05 0.04 
248 PHE Cβ 0.21 0.24 0.15 0.23 0.06 -0.04 
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249 ARG C' 0.40 0.62     
249 ARG Cα 0.32 0.28 0.28 0.42 0.04 0.09 
249 ARG Cβ 0.22 0.19 0.22 0.27 0.00 0.01 
249 ARG Cγ 0.14 0.19 0.13 0.13 0.01 0.00 
250 LEU Cα 0.65 0.73     
250 LEU Cβ 0.82 0.84     
251 SER C' 0.28 0.49 0.10 0.07 0.18 0.27 
251 SER Cα 0.29 0.46 0.04 0.07 0.25 0.36 
251 SER Cβ 0.23 0.48 -0.18 -0.03 0.41 0.39 
252 ALA C' 0.17 0.34 0.00 0.14 0.17 0.11 
252 ALA Cα 0.12 0.30 0.02 0.13 0.10 0.22 
252 ALA Cβ 0.04 0.14 -0.05 0.03 0.09 0.09 
253 ASP C' 0.27 0.22     
253 ASP Cα 0.16 0.50     
253 ASP Cβ 0.07 0.33     
253 ASP Cγ -0.12 0.36     
254 ASP C' 0.86 0.85 0.76 0.50 0.10 0.22 
254 ASP Cα 0.83 0.54 0.64 0.04 0.19 0.31 
254 ASP Cβ 1.08 0.91 0.90 0.38 0.18 0.27 
254 ASP Cγ 1.00 0.89     
255 ILE C' 0.43 0.51 0.47 0.30 -0.03 -0.03 
255 ILE Cα 0.56 0.64 0.57 0.53 -0.02 0.11 
255 ILE Cβ 0.37 0.39 0.45 0.42 -0.08 0.05 
255 ILE Cγ1 0.46 0.50 0.53 0.58 -0.06 0.12 
255 ILE Cγ2 0.25 0.33 0.42 0.38 -0.16 0.02 
255 ILE Cδ1 0.29 0.38 0.40 0.43 -0.11 0.02 
256 ARG C' 0.30 0.19 0.29 0.17 0.01 0.04 
256 ARG Cα 0.19 0.07 0.21 0.06 -0.02 0.03 
256 ARG Cβ 0.08 0.41 0.05 0.42 0.03 0.00 
257 GLY C' 0.75 0.82 0.72 0.89   
257 GLY Cα 0.51 0.57 0.45 0.68   
258 ILE C' 0.82 1.14 0.84 0.69   
258 ILE Cα 1.14 1.18 1.13 1.01   
258 ILE Cβ 1.44 1.55 1.43 1.53   
258 ILE Cγ1 1.60 1.63 1.58 1.68   
258 ILE Cγ2 1.14 1.27 1.14 1.33   
258 ILE Cδ1 2.01 2.09 1.98 2.06   
259 GLN Cα 0.44 0.56 0.52 0.79 -0.07 0.04 
259 GLN Cβ 0.30 0.45 0.42 0.54 -0.12 -0.15 
259 GLN Cγ 0.35 0.42 0.47 0.52 -0.13 -0.16 
259 GLN Cδ 0.18 0.19 0.38 0.39 -0.20 -0.27 
260 SER C' 0.30 0.53 0.34 0.44   
260 SER Cα 0.24 0.37 0.30 0.31 -0.06 0.05 
260 SER Cβ 0.16 0.22 0.21 0.15 -0.04 0.04 
261 LEU C' 0.51 0.53 0.52 0.45   
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261 LEU Cα 0.50 0.61 0.53 0.64   
261 LEU Cβ 0.72 0.75 0.73 0.78   
261 LEU Cγ 0.71 1.01     
261 LEU Cδ1 1.08 0.83 1.09 0.63   
261 LEU Cδ2 0.44 0.69     
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2.5 Conclusions 
In conclusion, we demonstrated that, in the investigation of paramagnetic proteins in the 
solid-state, it is possible to experimentally separate the intra-molecular pcs from the inter-
molecular contributions by using paramagnetic diluted samples. These pcs are effective 
structural restraints: intra-molecular pcs can be used as restraints for protein structure 
determinations in the solid state, while inter-molecular pcs can be used to obtain spatial 
arrangements among different protein molecules, not necessarily in a crystalline state. The 
calculation performed, directly or indirectly on the inter-molecular contributions 
demonstrates that pcs alone are accurate enough to allow one to determine the position and 
the orientation of two neighboring protein molecules with a distance of very few Å from the 
values determined from X-ray crystallography. We stress the fact that only NMR pcs 
restraints are used, with no other information coming from crystallography apart from the 
single protein structure. This can be in principle determined from solid-state NMR 
measurements (e.g. by using intra-molecular pcs) or, when possible by using solution NMR 
structures. 
We believe to be able to demonstrate in this work a simple strategy to extract valuable pcs 
restraints and their applicability as structural constraints. Most importantly we were able to 
use these restraints in order to get a rapid image structure of a moderately large protein. 
Minimal effort was given in extracting a large number distance inter-nuclear distance 
restraints, usually required to obtain a suitable fold of a protein. These results indicate that 
structure determination based on dipolar paramagnetic (pseudocontact) shifts is applicable to 
molecules containing anisotropic paramagnetic centers with short electronic relaxation times, 
including numerous naturally occurring metalloproteins, as well as proteins or nucleic acids 
to which a paramagnetic metal ion or ligand may be attached in Solid-state NMR as well. 
Moreover, since this method has been demonstrated to work with uniformly labeled sample 
this could be extremely useful to study systems in general and where specific labeling would 
not be feasible as well. 
These results allow this method to be applied to biomolecules in solid-phase that are not 
necessarily crystalline, but endowed with a one-dimensional order such as fibrils, which 
cannot be structurally investigated by X-ray crystallography. It is worth recalling that 
paramagnetic metals, besides being incorporated in metalloproteins in the place of 
diamagnetic ones, can be also attached as tags to any protein, and this renders the approach 
quite general.  
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Recent advances in genomic sequencing, molecular, cellular biology and bioinformatic 
methods for gene annotation presage significant improvements in human health, if the 
increased knowledge can be translated into effective therapeutics. Structural biology is one 
of the most informative disciplines providing knowledge of the potential targets for small 
molecule interactions of possible use as pharmaceutical leads or for further development of 
therapeutics. NMR spectroscopy (both liquid-state and solid-state NMR) is a unique tool due 
to its versatility and high-throughput capabilities, together with the ability of the technology 
for target identification, atomic level information of their structure and thus their surface and 
pocket characteristics for interactions. Furthermore, it is uniquely powerful in the early 
phases of drug discovery, because it allows screening over a wide range of affinities (mM-
nM). It is important to note that molecules that bind with even weak binding constants are 
very valuable because they provide indication of the type of compounds and functionalities 
suitable for targeting the receptors’ binding pocket.  
 
In these three years I have been involved with two different methodological NMR projects 
aimed at i) testing the possibility of identifying small molecules to inhibit protein-protein 
interactions and ii) developing methods for obtaining structural information on proteins 
containing  paramagnetic probes in the solid state. 
In the first project we focused our attention on two members of the S100 family: S100A13 
and S100B. The first one is involved in the non-classical protein release of two pro-
angiogenic polypeptides FGF-1 and IL-1α that are involved in inflammatory processes, 
while S100B is known to interact with the C-terminal domain of the intracellular tumour 
suppressor p53 and promote cancer development. We screened, using waterLOGSY NMR 
experiments, 430 molecules of a generic fragment library and we identified different hits for 
each protein. The subset of fragments interacting with S100B has very few members in 
common with the subset interacting with S100A13. From the 15N-HSQC NMR spectra of the 
proteins in the presence of those hits the chemical shift differences ∆δ(HN) were calculated. 
Coupling of the experimental data with docking results indicated the most probable docked 
conformations of the ligands on the proteins surface. For example: the anti-allergic drug 
cromolyn provided for the first time structural information for the interaction, and 
demonstrated that cromolyn has a unique binding site on the protein surface.. A relatively 
large variety of interaction regions for various ligands were identified for the two proteins, 
including known or suggested protein-protein interaction sites.  Although, the two proteins 
have quite similar quaternary structure and a common binding area (around the hinge loop), 
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our results showed that they have in common only few ligands. This indicates that selective 
leads could be developed starting from the different ligands, with high LE values, here 
identified. Moreover, this study indicates that screening a family of protein is more 
informative than screening one member of the family. Hence, one of the future perspectives 
would be to extend this screening study with other members of this S100 family. The library 
used for this work is an implementation of a slightly smaller library used for a screening 
conducted on the protein cytochrome c (Assfalg et al. Biochemistry 2007, 46, 6232-6238).  
The waterLOGSY experiments under the same experimental conditions indicate a hit rate of 
about 5%. The experiments conducted reveals 56 hits for S100A13 (51 with moderate and 5 
with strong binding), 48 hits for S100B (28 with moderate and 20 with strong shift) and 25 
hits for cytochrome c (see Figure 11 in the main text of part 1). Only few of the selected hits 
bind on more than one target. This data also indicate that the present library, although small 
(partly because it is made by smaller than usual fragments), is well suited to make initial 
guesses about selectivity. This was planned to obtain initial hints on the druggability of the 
target and to decide how to orient further screening efforts. The next effort will be to build 
larger libraries around those fragments which are more promising. Finally, the data reported 
in the paper show that α−napthol is able to displace only partially the p53-peptide from 
S100B. This shows that it is worth trying to design a α-napthol derivative that could be able 
to displace completely the p53-peptide.  
In the second part of our research our target is to develop additional sources of structural 
restraints in SSNMR of metalloproteins, through the analysis of the paramagnetic 
contribution. In solution NMR the most used distance restraints are obtained from inter-
residual 1H-1H NOEs. In SSNMR structural information is obtained through 13C-13C dipolar 
recoupling techniques, such as Proton Driven Spin Diffusion (PDSD) or CHHC experiments. 
Even using additional dihedral angle restraints obtained from backbone chemical shifts 
(through Chemical Shift Index (CSI) or TALOS program), the paucity of restraints limits the 
size of the affordable proteins, and often require selective labeling techniques. We have 
shown how a combined strategy of protein labeling and dilution of the paramagnetic species 
allows one to easily separate the pcs contributions originated by the protein internal metal 
(intra-molecular pcs) from those due to the metals in neighboring proteins in the crystal 
lattice (inter-molecular pcs). We have demonstrated that the intra-molecular pcs allow one 
to strongly reduce the number of distance restraints needed to obtain a low-resolution protein 
structure. These intra-molecular pcs along with additional restraints, the backbone dihedral 
angles determined through programs such as TALOS or Chemical Shift Index (CSI) improve 
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the RMSD of the calculated family of structures. Furthermore, the inter-molecular pcs 
provide unique information on the protein arrangement in the solid phase, determining 
positions and orientations of neighbouring protein molecules. The results are in good 
agreement with X-ray data. This approach is distinctively based on the paramagnetic solid-
state NMR data and can be applied also to ordered non-crystalline systems such as fibrils, 
providing useful information on their aggregation state.  
Thus a reliable perspective in this sense is the use of paramagnetic based structural restraints, 
such as pseudocontact shifts (pcs), to support the diamagnetic based restraints. Since pcs can 
be easily determined, and in large amount from the SSNMR protein assignment, they have a 
potential great impact in the structural determination allowing, in perspective, a possible 
increase in the size of the biomolecules affordable through SSNMR. Besides, pseudocontact 
shifts are long distance restraints. Using metals with a sizable anisotropy of the magnetic 
susceptibility (Co(II), Ln,…) they can be detected up to 30-35 Å from the paramagnetic 
center. For such a reason, it should not be unusual to observe in SSNMR of metalloproteins 
inter-molecular pcs, where the metal bound to a protein molecule influences the shifts of 
neighboring molecules. Once these contributions are isolated, for example by using 
paramagnetically diluted samples, they are useful structural restraints to determine the 
protein arrangement in the solid phase. This perspective is especially important as it can be 
applied to one-dimensional ordered systems such as amyloids, for which information about 
their structure or the protein aggregation are hardly obtained through other techniques as X-
ray diffraction. Moreover, this strategy can be extended to biomolecules that do not bind 
metal by using paramagnetic tags. In this case, paramagnetic and diamagnetic analogous 
proteins are easily obtained by changing the metal bound in the protein tag. Paramagnetic 
restraints should be detected even more easily than in solution NMR, as problems connected 
with the mobility of the tag should be absent in the solid phase. 
 Another interesting future perspective would be the exploitation of paramagnetic NMR in 
the solid-state, taking advantage of the technological improvement concerning the 
development of fast and very-fast MAS probes, and the accessibility of high-field magnets. 
The former would allow a stronger suppression of the paramagnetic shift anisotropy effects 
which might make the investigation of metals with strong magnetic susceptibility (such as 
lanthanides) possible. The latter is expected to produce an appreciable increase in sensibility 
and resolution of paramagnetic SSNMR spectra. Indeed, as in the NMR of paramagnetic 
solids the line broadening due to Curie relaxation, which depends on molecular tumbling and 
increases with the square of the field, is absent, the sensitivity can sizably increase operating 
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at high magnetic fields. 1H detection in SSNMR is another important perspectives of this 
technique. The advantages in the proton detection are connected to its higher sensitivity and 
to the possibility to extend the sources of structural restraints. The investigation of 
perdeuterated sample, the use of very-fast MAS techniques, as well as the development of 
1H homo-decoupling sequences are some possible perspectives of expansion of this field. As 
far the study of paramagnetic samples is concerned, the absence of Curie relaxation makes it 
possible, in principle, to observe signal much more closer to the metal compared to what can 
be done in solution. The proton pcs could thus provide another important source of structural 
restraints. 
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